UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM
(Mark One)
For the quarterly period ended
OR
For the transition period from ________________________ to ________________________
Commission file number
(Exact name of registrant as specified in its charter)
(State or other jurisdiction of | (I.R.S. Employer Identification No.) |
incorporation or organization) |
| |
(Address of Principal Executive Offices) | (Zip Code) |
Registrant’s telephone number, including area code: (
Securities registered pursuant to Section 12(b) of the Act:
Title of each class |
| Trading Symbol(s) |
| Name of each exchange on which registered |
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
☒ | ☐ Accelerated filer | ☐ Non-accelerated filer |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No
Number of shares of $1 par value common stock outstanding as of October 24, 2020:
AVERY DENNISON CORPORATION
FISCAL THIRD QUARTER 2020 QUARTERLY REPORT ON FORM 10-Q
TABLE OF CONTENTS
Safe Harbor Statement
The matters discussed in this Quarterly Report contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These statements, which are not statements of historical fact, contain estimates, assumptions, projections and/or expectations regarding future events, which may or may not occur. Words such as “aim,” “anticipate,” “assume,” “believe,” “continue,” “could,” “estimate,” “expect,” “foresee,” “guidance,” “intend,” “may,” “might,” “objective,” “plan,” “potential,” “project,” “seek,” “shall,” “should,” “target,” “will,” “would,” or variations thereof, and other expressions that refer to future events and trends, identify forward-looking statements. These forward-looking statements, and financial or other business targets, are subject to certain risks and uncertainties, which could cause our actual results to differ materially from the expected results, performance or achievements expressed or implied by such forward-looking statements.
We believe that the most significant risk factors that could affect our financial performance in the near-term include: (1) the impacts to our business from global economic conditions, political uncertainty, and changes in governmental regulations, including as a result of the coronavirus/COVID-19 pandemic; (2) competitors' actions, including pricing, expansion in key markets, and product offerings; (3) the degree to which higher costs can be offset with productivity measures and/or passed on to customers through price increases, without a significant loss of volume; and (4) the execution and integration of acquisitions.
The more significant risks and uncertainties that may impact us are discussed in more detail under “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our Annual Report on Form 10-K for the fiscal year ended December 28, 2019, and subsequent quarterly reports on Form 10-Q. These risks and uncertainties include, but are not limited to the following: the coronavirus/COVID-19 pandemic; fluctuations in demand affecting sales to customers; worldwide and local economic and market conditions; changes in political conditions; fluctuations in foreign currency exchange rates and other risks associated with foreign operations, including in emerging markets; changes in our markets due to competitive conditions, technological developments, laws and regulations, and customer preferences; fluctuations in the cost and availability of raw materials and energy; changes in governmental laws and regulations; the impact of competitive products and pricing; the financial condition and inventory strategies of customers; our ability to generate sustained productivity improvement; our ability to achieve and sustain targeted cost reductions; loss of significant contracts or customers; collection of receivables from customers; selling prices; business mix shift; execution and integration of acquisitions; product and service quality; timely development and market acceptance of new products, including sustainable or sustainably-sourced products; investment in development activities and new production facilities; amounts of future dividends and share repurchases; customer and supplier concentrations or consolidations; fluctuations in interest and tax rates; changes in tax laws and regulations, and uncertainties associated with interpretations of such laws and regulations; retention of tax incentives; outcome of tax audits; successful implementation of new manufacturing technologies and installation of manufacturing equipment; disruptions in information technology systems, including cyber-attacks or other intrusions to network security; successful installation of new or upgraded information technology systems; data security breaches; volatility of financial markets; impairment of capitalized assets, including goodwill and other intangibles; credit risks; our ability to obtain adequate financing arrangements and maintain access to capital; the realization of deferred tax assets; fluctuations in interest rates; compliance with our debt covenants; fluctuations in pension, insurance, and employee benefit costs; goodwill impairment; the impact of legal and regulatory proceedings, including with respect to environmental, health and safety, anti-corruption and trade compliance; protection and infringement of intellectual property; the impact of epidemiological events on the economy and our customers and suppliers; acts of war, terrorism, and natural disasters; and other factors.
Our forward-looking statements are made only as of the date hereof. We assume no duty to update these forward-looking statements to reflect new, changed or unanticipated events or circumstances, other than as may be required by law.
1
PART I. FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS
CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited)
(Dollars in millions, except per share amount) |
| September 26, 2020 |
| December 28, 2019 | ||
Assets | ||||||
Current assets: | ||||||
Cash and cash equivalents | $ | | $ | | ||
Trade accounts receivable, less allowances of $ |
| |
| | ||
Inventories, net |
| |
| | ||
Other current assets |
| |
| | ||
Total current assets |
| |
| | ||
Property, plant and equipment, net | | | ||||
Goodwill |
| |
| | ||
Other intangibles resulting from business acquisitions, net |
| |
| | ||
Deferred tax assets |
| |
| | ||
Other assets |
| |
| | ||
$ | | $ | | |||
Liabilities and Shareholders’ Equity | ||||||
Current liabilities: | ||||||
Short-term borrowings and current portion of long-term debt and finance leases | $ | | $ | | ||
Accounts payable |
| |
| | ||
Accrued payroll and employee benefits | | | ||||
Other current liabilities |
| |
| | ||
Total current liabilities |
| |
| | ||
Long-term debt and finance leases |
| |
| | ||
Long-term retirement benefits and other liabilities |
| |
| | ||
Deferred tax liabilities and income taxes payable |
| |
| | ||
Commitments and contingencies (see Note 12) | ||||||
Shareholders’ equity: | ||||||
Common stock, $ |
| |
| | ||
Capital in excess of par value |
| |
| | ||
Retained earnings |
| |
| | ||
Treasury stock at cost, |
| ( |
| ( | ||
Accumulated other comprehensive loss |
| ( |
| ( | ||
Total shareholders’ equity |
| |
| | ||
$ | | $ | |
See Notes to Unaudited Condensed Consolidated Financial Statements
2
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(Unaudited)
Three Months Ended | Nine Months Ended | |||||||||||
(In millions, except per share amounts) |
| September 26, 2020 |
| September 28, 2019 |
| September 26, 2020 |
| September 28, 2019 | ||||
Net sales | $ | | $ | | $ | | $ | | ||||
Cost of products sold |
| |
| |
| |
| | ||||
Gross profit |
| |
| |
| |
| | ||||
Marketing, general and administrative expense |
| |
| |
| |
| | ||||
Other expense (income), net |
| |
| |
| |
| | ||||
Interest expense | | | | | ||||||||
Other non-operating expense (income), net | | | ( | | ||||||||
Income before taxes |
| |
| |
| |
| | ||||
Provision for (benefit from) income taxes |
| |
| |
| |
| ( | ||||
Equity method investment (losses) gains | ( | ( | ( | ( | ||||||||
Net income | $ | | $ | | $ | | $ | | ||||
Per share amounts: | ||||||||||||
Net income per common share | $ | | $ | | $ | | $ | | ||||
Net income per common share, assuming dilution | $ | | $ | | $ | | $ | | ||||
Weighted average number of shares outstanding: |
|
|
| |||||||||
Common shares | | | | | ||||||||
Common shares, assuming dilution | | | | |
See Notes to Unaudited Condensed Consolidated Financial Statements
3
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(Unaudited)
Three Months Ended | Nine Months Ended | |||||||||||
(In millions) |
| September 26, 2020 |
| September 28, 2019 |
| September 26, 2020 |
| September 28, 2019 | ||||
Net income | $ | | $ | | $ | | $ | | ||||
Other comprehensive income (loss), net of tax: | ||||||||||||
Foreign currency translation |
| |
| ( |
| ( |
| ( | ||||
Pension and other postretirement benefits |
| |
| |
| |
| | ||||
Cash flow hedges |
| ( |
| ( |
| ( |
| ( | ||||
Other comprehensive income (loss), net of tax |
| |
| ( |
| ( |
| | ||||
Total comprehensive income, net of tax | $ | | $ | | $ | | $ | |
See Notes to Unaudited Condensed Consolidated Financial Statements
4
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
Nine Months Ended | ||||||
(In millions) |
| September 26, 2020 |
| September 28, 2019 | ||
Operating Activities | ||||||
Net income | $ | | $ | | ||
Adjustments to reconcile net income to net cash provided by operating activities: | ||||||
Depreciation |
| |
| | ||
Amortization |
| |
| | ||
Provision for credit losses and sales returns | | | ||||
Stock-based compensation |
| |
| | ||
Pension plan settlements and related charges |
| — |
| | ||
Deferred taxes and other non-cash taxes | | ( | ||||
Other non-cash expense and loss (income and gain), net |
| |
| | ||
Changes in assets and liabilities and other adjustments |
| ( |
| ( | ||
Net cash provided by operating activities |
| |
| | ||
Investing Activities | ||||||
Purchases of property, plant and equipment |
| ( |
| ( | ||
Purchases of software and other deferred charges |
| ( |
| ( | ||
Proceeds from sales of property, plant and equipment |
| |
| | ||
Proceeds from insurance and sales (purchases) of investments, net |
| |
| | ||
Payments for acquisition, net of cash acquired, and investments in businesses |
| ( |
| ( | ||
Net cash used in investing activities |
| ( |
| ( | ||
Financing Activities | ||||||
Net increase (decrease) in borrowings (maturities of three months or less) |
| ( |
| | ||
Additional borrowings under revolving credit facility | | — | ||||
Repayments of revolving credit facility | ( | — | ||||
Additional long-term borrowings | | — | ||||
Repayments of long-term debt and finance leases |
| ( |
| ( | ||
Dividends paid |
| ( |
| ( | ||
Share repurchases |
| ( |
| ( | ||
Net (tax withholding) proceeds related to stock-based compensation |
| ( |
| ( | ||
Payments of contingent consideration | — | ( | ||||
Net cash used in financing activities |
| ( |
| ( | ||
Effect of foreign currency translation on cash balances |
| |
| ( | ||
Increase (decrease) in cash and cash equivalents |
| |
| ( | ||
Cash and cash equivalents, beginning of year |
| |
| | ||
Cash and cash equivalents, end of period | $ | | $ | |
See Notes to Unaudited Condensed Consolidated Financial Statements
5
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
Note 1. General
The unaudited Condensed Consolidated Financial Statements and notes thereto in this Quarterly Report on Form 10-Q are presented as permitted by Article 10 of Regulation S-X and do not contain certain information included in the audited Consolidated Financial Statements and notes thereto in our 2019 Annual Report on Form 10-K, which should be read in conjunction with this Quarterly Report on Form 10-Q. These unaudited Condensed Consolidated Financial Statements contain all adjustments of a normal and recurring nature necessary for a fair statement of our interim results. Interim results of operations are not necessarily indicative of future results.
We expect the effects of the coronavirus/COVID-19 pandemic (collectively referred to herein as "COVID-19") to negatively impact our financial position, results of operations, and cash flows in fiscal year 2020, most significantly in our Retail Branding and Information Solutions ("RBIS") and Industrial and Healthcare Materials reportable segments.
The unaudited Condensed Consolidated Financial Statements presented herein reflect our current estimates and assumptions that affect the reported amounts of assets and liabilities and related disclosures as of the date of the financial statements and the reported amounts of sales and expenses during the reporting periods presented.
Fiscal Periods
The three and nine months ended September 26, 2020 and September 28, 2019 consisted of thirteen-week and thirty-nine week periods, respectively.
Accounting Guidance Update
Credit Losses
In the first quarter of 2020, using the modified retrospective approach, we adopted amended accounting guidance that requires credit losses on financial instruments, including trade receivables, to be measured based on the expected credit loss model instead of the incurred loss model. The expected credit loss model requires us to consider forward-looking information to estimate our allowance for credit losses. Our adoption of this guidance did not have a material impact on our financial position, results of operations or cash flows.
Note 2. Acquisitions
On February 28, 2020, we completed the acquisition of Smartrac’s Transponder (RFID Inlay) division ("Smartrac"), a manufacturer of radio-frequency identification (“RFID”) products, for consideration of approximately $
Note 3. Goodwill and Other Intangibles Resulting from Business Acquisitions
Changes in the net carrying amount of goodwill for the nine months ended September 26, 2020 by reportable segment are shown below.
Label and | Retail Branding | Industrial and | ||||||||||
Graphic | and Information | Healthcare | ||||||||||
(In millions) |
| Materials |
| Solutions |
| Materials |
| Total | ||||
Goodwill as of December 28, 2019 | $ | | $ | | $ | | $ | | ||||
Acquisition(1) | – | | – | | ||||||||
Translation adjustments |
| |
| | |
| | |||||
Goodwill as of September 26, 2020 | $ | | $ | | $ | | $ | |
(1)Goodwill acquired related to the acquisition of Smartrac. The amount of goodwill recognized is not expected to be deductible for income tax purposes.
The duration and severity of COVID-19 could result in future impairment charges to our reportable segments’ goodwill balances. While we have concluded that a triggering event did not occur during the nine months ended September 26, 2020, a prolonged pandemic could significantly impact our results of operations and result in changes to the assumptions we utilize in determining the estimated fair values of goodwill, which could trigger an impairment.
6
Finite-Lived Intangible Assets
In connection with the Smartrac acquisition, we acquired approximately $
The table below summarizes the amounts and useful lives of these intangible assets as of the acquisition date.
|
| Amortization | |||
Amount | period | ||||
(in millions) | (in years) | ||||
Patents and other acquired technology | $ | |
| ||
Customer relationships |
| |
| ||
Trade names and trademarks |
| |
|
Refer to Note 2, “Acquisitions,” to the unaudited Condensed Consolidated Financial Statements for more information.
Note 4. Debt
In March 2020, we issued $
In the second quarter of 2020, we also repaid $
The estimated fair value of our long-term debt is primarily based on the credit spread above U.S. Treasury securities or euro government bond securities, as applicable, on notes with similar rates, credit ratings, and remaining maturities. The fair value of short-term borrowings, which include commercial paper issuances and short-term lines of credit, approximates their carrying value given the short duration of these obligations. The fair value of our total debt was $
In February 2020, we amended and restated our $
Note 5. Pension and Other Postretirement Benefits
Defined Benefit Plans
We sponsor a number of defined benefit plans, the accrual of benefits under some of which has been frozen, covering eligible employees in the U.S. and certain other countries. Benefits payable to an employee are based primarily on years of service and the employee’s compensation during his or her employment with us. For the three months and nine months ended September 26, 2020, the net periodic benefit cost related to our U.S. and international plans was not material. For the three months and nine months ended September 28, 2019, the combined net periodic benefit cost related to our U.S. and international plans was $
7
In connection with the ADPP termination in 2019, we settled approximately $
Service cost and components of net periodic benefit cost (credit) other than service cost were included in “Marketing, general and administrative expense” and “Other non-operating expense (income), net” in the unaudited Condensed Consolidated Statements of Income, respectively.
We are also obligated to pay unfunded termination indemnity benefits to certain employees outside of the U.S., which are subject to applicable agreements, laws and regulations. We did not incur significant costs related to these benefits in the nine months ended September 26, 2020 or September 28, 2019.
Note 6. Cost Reduction Actions
2019/2020 Actions
During the nine months ended September 26, 2020, we recorded $
During the nine months ended September 26, 2020, restructuring charges and payments were as follows:
Charges, | Foreign | |||||||||||||||||
Accrual at | Net of | Cash | Non-cash | Currency | Accrual at | |||||||||||||
(In millions) |
| December 28, 2019 |
| Reversals |
| Payments |
| Impairment |
| Translation |
| September 26, 2020 | ||||||
2019/2020 Actions | ||||||||||||||||||
Severance and related costs | $ | | $ | | $ | ( | $ | — | $ | | $ | | ||||||
Asset impairment | | | — | ( | — | | ||||||||||||
2018/2019 Actions | ||||||||||||||||||
Severance and related costs | | — | ( | — | | | ||||||||||||
Lease cancellation costs | | — | — | — | — | | ||||||||||||
Total | $ | | $ | | $ | ( | $ | ( | $ | | $ | |
Accruals for severance and related costs, as well as lease cancellation costs, were included in “Other current liabilities” in the unaudited Condensed Consolidated Balance Sheets. Asset impairment charges were based on the estimated market value of the assets, less selling costs, if applicable. Restructuring charges were included in “Other expense (income), net” in the unaudited Condensed Consolidated Statements of Income.
The table below shows the total amount of restructuring charges, net of reversals, incurred by reportable segment and Corporate.
Three Months Ended | Nine Months Ended | |||||||||||
(In millions) |
| September 26, 2020 |
| September 28, 2019 |
| September 26, 2020 |
| September 28, 2019 | ||||
Restructuring charges, net of reversals, by reportable segment and Corporate | ||||||||||||
Label and Graphic Materials | $ | | $ | | $ | | $ | | ||||
Retail Branding and Information Solutions |
| |
| |
| |
| | ||||
Industrial and Healthcare Materials |
| |
| |
| |
| | ||||
Corporate | — | — | ( | — | ||||||||
Total | $ | | $ | | $ | | $ | |
8
Note 7. Financial Instruments
We enter into foreign exchange hedge contracts to reduce our risk from foreign exchange rate fluctuations associated with receivables, payables, loans and firm commitments denominated in certain foreign currencies that arise primarily as a result of our operations outside the U.S. We also enter into futures contracts to hedge certain price fluctuations for a portion of our anticipated domestic purchases of natural gas. The impact of these foreign exchange and commodities hedge activities on our unaudited Condensed Consolidated Financial Statements was not significant.
Following our Smartrac acquisition and our issuance of senior notes in March 2020, we entered into U.S. dollar to euro cross-currency swap contracts with a total notional amount of $
Note 8. Taxes Based on Income
The following table summarizes our income before taxes, provision for (benefit from) income taxes, and effective tax rate:
Three Months Ended | Nine Months Ended | |||||||||||||
(Dollars in millions) |
| September 26, 2020 |
| September 28, 2019 |
| September 26, 2020 |
| September 28, 2019 | ||||||
Income before taxes | $ | | $ | | $ | | $ | | ||||||
Provision for (benefit from) income taxes |
| |
| |
| |
| ( | ||||||
Effective tax rate |
| | % |
| | % |
| | % |
| ( | % |
Our provision for (benefit from) income taxes for the three and nine months ended September 26, 2020 included $
Our provision for (benefit from) income taxes for the three and nine months ended September 26, 2020 was not materially affected by COVID-19. Moreover, our ability to generate sufficient taxable income was not adversely affected in certain jurisdictions where a significant portion of our net deferred tax assets is concentrated. Our provision for (benefit from) income taxes for the three and nine months ended September 26, 2020 was not materially impacted by the stimulus packages and subsequent interpretations enacted in the U.S. and other countries to provide economic relief to businesses in response to COVID-19.
Our provision for (benefit from) income taxes for the three and nine months ended September 28, 2019 included $
9
“Accumulated other comprehensive income” through the unaudited Condensed Consolidated Statements of Income. The tax effects were stranded primarily as a result of the U.S. federal tax rate change under the U.S. Tax Cuts and Jobs Act. Refer to Note 5, “Pension and Other Postretirement Benefits,” to the unaudited Condensed Consolidated Financial Statements for more information on the termination of the ADPP.
The amount of income taxes we pay is subject to ongoing audits by taxing jurisdictions around the world. Our estimate of the potential outcome of any uncertain tax issue is subject to our assessment of the relevant risks, facts, and circumstances existing at the time. We believe that we have adequately provided for reasonably foreseeable outcomes related to these matters. However, our future results may include favorable or unfavorable adjustments to our estimated tax liabilities in the period the assessments are made or resolved, which may impact our effective tax rate. The final determination of tax audits and any related legal proceedings could materially differ from the amounts currently reflected in our tax provision and the related liabilities. To date, we and our U.S. subsidiaries have completed the IRS’ Compliance Assurance Process Program through 2017. With limited exceptions, we are no longer subject to income tax examinations by tax authorities for years prior to 2010.
During the third quarter of 2020, we completed an analysis related to a foreign withholding tax regime that could be interpreted to subject us to withholding tax compliance requirements on certain cross-border intellectual property transactions for years remaining open under the applicable statutes of limitations. Our interpretation concluded that the application of the withholding tax regime would not have a material impact on our financial position, results of operations or cash flows.
On July 20, 2020, the U.S. Department of Treasury released final regulations that provide certain U.S. taxpayers with an annual election to exclude foreign income that is subject to a high effective tax rate from their GILTI inclusions. These regulations apply beginning with our 2021 tax year with an option to retroactively apply them to our 2018 through 2020 tax years. During the third quarter of 2020, we did not reflect any impacts of this provision as we have not yet made our determination on whether to make the election for each of the applicable tax years. We continue to evaluate the impact of these regulations and currently anticipate that the benefits from electing these exclusions on our original or amended returns may be significant for certain years. We will reflect the impacts on our provision for (benefit from) income taxes upon the completion of our evaluation within the time allowed under applicable regulations.
Subsequent to the end of the third quarter of 2020, we met with tax authorities in a foreign jurisdiction on an audit for tax years 2016-2019 to discuss the application of incentive tax rates to our activities in the jurisdiction for those years. The response received during the meeting and in subsequent correspondence may lead to a change in our judgment with regard to our uncertain tax positions, which may have a significant adverse effect on our provision for (benefit from) income taxes in 2020.
It is reasonably possible that, during the next 12 months, we may realize a net decrease in our uncertain tax positions, including interest and penalties, of approximately $
10
Note 9. Net Income Per Common Share
Net income per common share was computed as follows:
| Three Months Ended | Nine Months Ended | |||||||||||
(In millions, except per share amounts) |
| September 26, 2020 |
| September 28, 2019 |
| September 26, 2020 |
| September 28, 2019 | |||||
(A) | Net income available to common shareholders | $ | | $ | | $ | | $ | | ||||
(B) | Weighted average number of common shares outstanding |
| |
| |
| |
| | ||||
Dilutive shares (additional common shares issuable under stock-based awards) |
| |
| |
| |
| | |||||
(C) | Weighted average number of common shares outstanding, assuming dilution |
| |
| |
| |
| | ||||
Net income per common share: (A) ÷ (B) | $ | | $ | | $ | | $ | | |||||
Net income per common share, assuming dilution: (A) ÷ (C) | $ | | $ | | $ | | $ | |
Certain stock-based compensation awards were not included in the computation of net income per common share, assuming dilution, because they would not have had a dilutive effect. Stock-based compensation awards excluded from the computation were not significant for the three and nine months ended September 26, 2020 or September 28, 2019.
11
Note 10. Supplemental Equity and Comprehensive Income Information
Consolidated Changes in Shareholders’ Equity
Three Months Ended | Nine Months Ended | |||||||||||
(In millions) |
| September 26, 2020 |
| September 28, 2019 |
| September 26, 2020 |
| September 28, 2019 | ||||
Common stock issued, $ | $ | | $ | | $ | | $ | | ||||
Capital in excess of par value | ||||||||||||
Beginning balance | $ | | $ | | $ | | $ | | ||||
Issuance of shares under stock-based compensation plans(1) |
| |
| |
| ( |
| ( | ||||
Ending balance | $ | | $ | | $ | | $ | | ||||
Retained earnings | ||||||||||||
Beginning balance | $ | | $ | | $ | | $ | | ||||
Net income |
| |
| |
| |
| | ||||
Issuance of shares under stock-based compensation plans(1) |
| — |
| — |
| ( |
| ( | ||||
Contribution of shares to 401(k) Plan(1) |
| |
| |
| |
| | ||||
Dividends |
| ( |
| ( |
| ( |
| ( | ||||
Ending balance | $ | | $ | | $ | | $ | | ||||
Treasury stock at cost | ||||||||||||
Beginning balance | $ | ( | $ | ( | $ | ( | $ | ( | ||||
Repurchase of shares for treasury |
| ( |
| ( |
| ( |
| ( | ||||
Issuance of shares under stock-based compensation plans(1) |
| |
| |
| |
| | ||||
Contribution of shares to 401(k) Plan(1) |
| |
| |
| |
| | ||||
Ending balance | $ | ( | $ | ( | $ | ( | $ | ( | ||||
Accumulated other comprehensive loss | ||||||||||||
Beginning balance | $ | ( | $ | ( | $ | ( | $ | ( | ||||
Other comprehensive income (loss), net of tax(2) |
|
| ( |
| ( |
| | |||||
Ending balance | $ | ( | $ | ( | $ | ( | $ | ( |
(1)We fund a portion of our employee-related expenses using shares of our common stock held in treasury. We reduce capital in excess of par value based on the grant date fair value of the awards vested and record net gains or losses associated with our use of treasury shares to retained earnings.
(2)In the first quarter of 2019, we effectively settled our remaining obligations under the ADPP. Refer to Note 5, “Pension and Other Postretirement Benefits,” to the unaudited Condensed Consolidated Financial Statements for more information.
Dividends per common share were as follows:
Three Months Ended | Nine Months Ended | |||||||||||
| September 26, 2020 |
| September 28, 2019 |
| September 26, 2020 |
| September 28, 2019 | |||||
Dividends per common share | $ | | $ | | $ | | $ | |
Changes in Accumulated Other Comprehensive Loss
The changes in “Accumulated other comprehensive loss” (net of tax) for the nine-month period ended September 26, 2020 were as follows:
Pension and | ||||||||||||
Foreign | Other | |||||||||||
Currency | Postretirement | Cash Flow | ||||||||||
(In millions) |
| Translation |
| Benefits |
| Hedges |
| Total | ||||
Balance as of December 28, 2019 | $ | ( | $ | ( | $ | ( | $ | ( | ||||
Other comprehensive income (loss) before reclassifications, net of tax |
| ( |
| — |
| ( |
| ( | ||||
Reclassifications to net income, net of tax |
| — |
| |
| |
| | ||||
Net current-period other comprehensive income (loss), net of tax |
| ( |
| |
| ( |
| ( | ||||
Balance as of September 26, 2020 | $ | ( | $ | ( | $ | ( | $ | ( |
12
The changes in “Accumulated other comprehensive loss” (net of tax) for the nine-month period ended September 28, 2019 were as follows:
Pension and | ||||||||||||
Foreign | Other | |||||||||||
Currency | Postretirement | Cash Flow | ||||||||||
(In millions) |
| Translation |
| Benefits |
| Hedges |
| Total | ||||
Balance as of December 29, 2018 | $ | ( | $ | ( | $ | ( | $ | ( | ||||
Other comprehensive income (loss) before reclassifications, net of tax(1) |
| ( |
| |
| ( |
| | ||||
Reclassifications to net income, net of tax(2) |
| — |
| |
| ( |
| | ||||
Net current-period other comprehensive income (loss), net of tax |
| ( |
| |
| ( |
| | ||||
Balance as of September 28, 2019 | $ | ( | $ | ( | $ | ( | $ | ( |
(1)Other comprehensive income (loss) before reclassifications, net of tax, for pension and other postretirement benefits related to the remeasurement of the ADPP’s net pension obligations and included tax of $
(2)Reclassifications to net income for pension and other postretirement benefits included losses of $
Note 11. Fair Value Measurements
Recurring Fair Value Measurements
The assets and liabilities carried at fair value, measured on a recurring basis, as of September 26, 2020 were as follows:
Fair Value Measurements Using | ||||||||||||
Significant | Significant | |||||||||||
Quoted Prices | Other | Other | ||||||||||
in Active | Observable | Unobservable | ||||||||||
Markets | Inputs | Inputs | ||||||||||
(In millions) |
| Total |
| (Level 1) |
| (Level 2) |
| (Level 3) | ||||
Assets | ||||||||||||
Investments | $ | | $ | | $ | | $ | — | ||||
Derivative assets |
| |
| |
| |
| — | ||||
Bank drafts | | | — | — | ||||||||
Liabilities | ||||||||||||
Derivative liabilities | $ | | $ | — | $ | | $ | — |
The assets and liabilities carried at fair value, measured on a recurring basis, as of December 28, 2019 were as follows:
Fair Value Measurements Using | ||||||||||||
Significant | Significant | |||||||||||
Quoted Prices | Other | Other | ||||||||||
in Active | Observable | Unobservable | ||||||||||
Markets | Inputs | Inputs | ||||||||||
(In millions) |
| Total |
| (Level 1) |
| (Level 2) |
| (Level 3) | ||||
Assets | ||||||||||||
Investments | $ | | $ | | $ | | $ | — | ||||
Derivative assets |
| |
| — |
| |
| — | ||||
Bank drafts | | | — | — | ||||||||
Liabilities | ||||||||||||
Derivative liabilities | $ | | $ | | $ | | $ | — |
13
Investments include fixed income securities (primarily U.S. government and corporate debt securities) measured at fair value using quoted prices/bids and a money market fund measured at fair value using net asset value. As of September 26, 2020, investments of $
Note 12. Commitments and Contingencies
Legal Proceedings
We are involved in various lawsuits, claims, inquiries, and other regulatory and compliance matters, most of which are routine to the nature of our business. When it is probable that a loss will be incurred and where a range of the loss can be reasonably estimated, the best estimate within the range is accrued. When the best estimate within the range cannot be determined, the low end of the range is accrued. The ultimate resolution of these claims could affect future results of operations should our exposure be materially different from our estimates or should liabilities be incurred that were not previously accrued. Potential insurance reimbursements are not offset against potential liabilities.
Because of the uncertainties associated with claims resolution and litigation, future expenses to resolve these matters could be higher than the liabilities we have accrued; however, we are unable to reasonably estimate a range of potential expenses. If information were to become available that allowed us to reasonably estimate a range of potential expenses in an amount higher or lower than what we have accrued, we would adjust our accrued liabilities accordingly. Additional lawsuits, claims, inquiries, and other regulatory and compliance matters could arise in the future. The range of expenses for resolving any future matters would be assessed as they arise; until then, a range of potential expenses for such resolution cannot be determined. Based upon current information, we believe that the impact of the resolution of these matters would not be, individually or in the aggregate, material to our financial position, results of operations or cash flows.
Environmental Expenditures
Environmental expenditures are generally expensed. However, environmental expenditures for newly acquired assets and those that extend or improve the economic useful life of existing assets are capitalized and amortized over the shorter of the estimated useful life of the acquired asset or the remaining life of the existing asset. We review our estimates of the costs of complying with environmental laws related to remediation and cleanup of various sites, including sites in which governmental agencies have designated us as a potentially responsible party (“PRP”). When it is probable that a loss will be incurred and where a range of the loss can be reasonably estimated, the best estimate within the range is accrued. When the best estimate within the range cannot be determined, the low end of the range is accrued. Potential insurance reimbursements are not offset against potential liabilities.
As of September 26, 2020, we have been designated by the U.S. Environmental Protection Agency (“EPA”) and/or other responsible state agencies as a PRP at
These estimates could change as a result of changes in planned remedial actions, remediation technologies, site conditions, the estimated time to complete remediation, environmental laws and regulations, and other factors. Because of the uncertainties associated with environmental assessment and remediation activities, our future expenses to remediate these sites could be higher than the liabilities we have accrued; however, we are unable to reasonably estimate a range of potential expenses. If information were to become available that allowed us to reasonably estimate a range of potential expenses in an amount higher or lower than what we have accrued, we would adjust our environmental liabilities accordingly. In addition, we may be identified as a PRP at additional sites in the future. The range of expenses for remediation of any future-identified sites would be addressed as they arise; until then, a range of expenses for such remediation cannot be determined.
14
The activity related to our environmental liabilities for the nine months ended September 26, 2020 was as follows:
(In millions) |
|
| |
Balance at December 28, 2019 | $ | | |
Charges, net of reversals |
| | |
Payments |
| ( | |
Balance at September 26, 2020 | $ | |
Approximately $
Note 13. Segment and Disaggregated Revenue Information
Disaggregated Revenue Information
Disaggregated revenue information is shown below in the manner that best depicts how the nature, amount, timing and uncertainty of our revenue and cash flows are affected by economic factors. Revenue from our LGM reportable segment is attributed to geographic areas based on the location from which products are shipped. Revenue from our RBIS reportable segment is shown by product group.
Three Months Ended | Nine Months Ended | |||||||||||
(In millions) |
| September 26, 2020 |
| September 28, 2019 |
| September 26, 2020 |
| September 28, 2019 | ||||
Net sales to unaffiliated customers |
|
|
|
|
|
|
|
| ||||
Label and Graphic Materials: |
|
|
|
|
|
|
|
| ||||
U.S. | $ | | $ | | $ | | $ | | ||||
Europe |
| |
| |
| |
| | ||||
Asia |
| |
| |
| |
| | ||||
Latin America |
| |
| |
| |
| | ||||
Other international |
| |
| |
| |
| | ||||
Total Label and Graphic Materials | | | | | ||||||||
Retail Branding and Information Solutions: |
|
|
|
| ||||||||
Apparel | | | | | ||||||||
Printer Solutions |
| |
| |
| |
| | ||||
Total Retail Branding and Information Solutions | | | | | ||||||||
Industrial and Healthcare Materials | | | | | ||||||||
Net sales to unaffiliated customers | $ | | $ | | $ | | $ | |
15
Additional Segment Information
Additional financial information by reportable segment and Corporate is shown below.
Three Months Ended | Nine Months Ended | |||||||||||
(In millions) |
| September 26, 2020 |
| September 28, 2019 |
| September 26, 2020 |
| September 28, 2019 | ||||
Intersegment sales | ||||||||||||
Label and Graphic Materials | $ | | $ | | $ | | $ | | ||||
Retail Branding and Information Solutions |
| |
| |
| |
| | ||||
Industrial and Healthcare Materials |
| |
| |
| |
| | ||||
Intersegment sales | $ | | $ | | $ | | $ | | ||||
Income before taxes | ||||||||||||
Label and Graphic Materials | $ | | $ | | $ | | $ | | ||||
Retail Branding and Information Solutions |
| |
| |
| |
| | ||||
Industrial and Healthcare Materials |
| |
| |
| |
| | ||||
Corporate expense |
| ( |
| ( |
| ( |
| ( | ||||
Interest expense |
| ( |
| ( |
| ( |
| ( | ||||
Other non-operating expense (income), net | ( | ( | | ( | ||||||||
Income before taxes | $ | | $ | | $ | | $ | | ||||
Other expense (income), net, by reportable segment and Corporate | ||||||||||||
Label and Graphic Materials | $ | | $ | | $ | | $ | | ||||
Retail Branding and Information Solutions |
| |
| |
| |
| | ||||
Industrial and Healthcare Materials | | | | | ||||||||
Corporate | — | | ( | | ||||||||
Other expense (income), net | $ | | $ | | $ | | $ | | ||||
Other expense (income), net, by type | ||||||||||||
Restructuring charges: | ||||||||||||
Severance and related costs | $ | | $ | | $ | | $ | | ||||
Asset impairment charges and lease cancellation costs |
| |
| — |
| |
| | ||||
Other items: | ||||||||||||
Loss on investment | | — | | — | ||||||||
Transaction and related costs | — | — | | — | ||||||||
Legal settlement | — | | — | | ||||||||
Gain on sales of assets | — | — | — | ( | ||||||||
Other expense (income), net | $ | | $ | | $ | | $ | |
Note 14. Supplemental Financial Information
Inventories
The table below summarizes the amounts in inventory, net.
(In millions) |
| September 26, 2020 |
| December 28, 2019 | ||
Raw materials | $ | | $ | | ||
Work-in-progress |
| |
| | ||
Finished goods |
| |
| | ||
Inventories, net | $ | | $ | |
16
Property, Plant and Equipment
The table below summarizes the amounts in property, plant and equipment, net.
(In millions) |
| September 26, 2020 |
| December 28, 2019 | ||
Property, plant and equipment | $ | | $ | | ||
Accumulated depreciation |
| ( |
| ( | ||
Property, plant and equipment, net | $ | | $ | |
Allowance for Credit Losses
Given the short-term nature of trade receivables, our allowance for credit losses is based on the financial condition of customers, the aging of receivable balances, our historical collection experience, and current and expected future macroeconomic and market conditions, including as a result of COVID-19. Balances are written off in the period in which they are determined to be uncollectible.
The activity for the nine months ended September 26, 2020 related to our allowance for credit losses was as follows:
(In millions) |
| ||
Balance at December 28, 2019 |
| $ | |
Provision for credit losses(1) | | ||
Amounts written off |
| ( | |
Other, including foreign currency translation |
| | |
Balance at September 26, 2020 | $ | |
(1)Primarily reflects estimated impacts on customers as a result of COVID-19.
17
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Management’s Discussion and Analysis of Financial Condition and Results of Operations, or MD&A, provides management’s views on our financial condition and results of operations and should be read in conjunction with the accompanying unaudited Condensed Consolidated Financial Statements and notes thereto.
NON-GAAP FINANCIAL MEASURES
We report our financial results in conformity with accounting principles generally accepted in the United States of America, or GAAP, and also communicate with investors using certain non-GAAP financial measures. These non-GAAP financial measures are not in accordance with, nor are they a substitute for or superior to, the comparable GAAP financial measures. These non-GAAP financial measures are intended to supplement presentation of our financial results that are prepared in accordance with GAAP. Based upon feedback from investors and financial analysts, we believe that the supplemental non-GAAP financial measures we provide are useful to their assessments of our performance and operating trends, as well as liquidity.
Our non-GAAP financial measures exclude the impact of certain events, activities or decisions. The accounting effects of these events, activities or decisions, which are included in the GAAP financial measures, may make it difficult to assess our underlying performance in a single period. By excluding the accounting effects, positive or negative, of certain items (e.g., restructuring charges, legal settlements, certain effects of strategic transactions and related costs, losses from debt extinguishments, gains or losses from curtailment or settlement of pension obligations, gains or losses on sales of certain assets, gains or losses on investments and other items), we believe that we are providing meaningful supplemental information that facilitates an understanding of our core operating results and liquidity measures. While some of the items we exclude from GAAP financial measures recur, they tend to be disparate in amount, frequency, or timing.
We use these non-GAAP financial measures internally to evaluate trends in our underlying performance, as well as to facilitate comparison to the results of competitors for a single period.
We use the following non-GAAP financial measures in this MD&A:
● | Sales change ex. currency refers to the increase or decrease in net sales, excluding the estimated impact of foreign currency translation, and, where applicable, currency adjustment for transitional reporting of highly inflationary economies (Argentina) and the reclassification of sales between segments. The estimated impact of foreign currency translation is calculated on a constant currency basis, with prior period results translated at current period average exchange rates to exclude the effect of currency fluctuations. |
● | Organic sales change refers to sales change ex. currency, excluding the estimated impact of product line exits, acquisitions and divestitures, and, where applicable, an extra week in our fiscal year. |
We believe that sales change ex. currency and organic sales change assist investors in evaluating the sales change from the ongoing activities of our businesses and enhance their ability to evaluate our results from period to period.
● | Free cash flow refers to cash flow provided by operating activities, less payments for property, plant and equipment, software and other deferred charges, plus proceeds from sales of property, plant and equipment, plus (minus) net proceeds from insurance and sales (purchases) of investments. Free cash flow is also adjusted for the cash contributions related to the termination of our U.S. pension plan. We believe that free cash flow assists investors by showing the amount of cash we have available for debt reductions, dividends, share repurchases, and acquisitions. |
● | Operational working capital as a percentage of annualized current quarter net sales refers to trade accounts receivable and inventories, net of accounts payable, and excludes cash and cash equivalents, short-term borrowings, deferred taxes, other current assets and other current liabilities, as well as net current assets or liabilities held-for-sale divided by annualized current quarter net sales. We believe that operational working capital as a percentage of annualized current quarter net sales assists investors in assessing our working capital requirements because it excludes the impact of fluctuations attributable to our financing and other activities (which affect cash and cash equivalents, deferred taxes, other current assets, and other current liabilities) that tend to be disparate in amount, frequency, or timing, and that may increase the volatility of working capital as a percentage of sales from period to period. The items excluded from this measure are not significantly influenced by our day-to-day activities managed at the operating level and do not necessarily reflect underlying trends in our operations. |
18
OVERVIEW AND OUTLOOK
COVID-19 Pandemic
In March 2020, the World Health Organization declared the outbreak of coronavirus/COVID-19 (collectively referred to herein as “COVID-19”) a pandemic, which has continued spreading throughout the U.S. and the world, resulting in governmental authorities implementing numerous containment measures, including travel bans and restrictions, quarantines, shelter-in-place orders, and business limitations and shutdowns.
The safety and well-being of our employees has been and will continue to be our top priority during this global crisis, followed immediately by continuing to deliver high quality products and service to our customers. We created global, regional, and local emergency response teams to manage immediate priorities, recognizing that some of our businesses serve a critical role in supply chains for essential goods such as food, hygiene, and pharmaceutical products, as well as e-commerce. To support the health and well-being of our employees, customers, partners and communities, the majority of our office-based employees continue to work remotely and some of our operations limited production or ceased operations for short periods of time. We leveraged learnings from our early experience in China to develop safety protocols for our manufacturing facilities to re-open and/or remain operational, and established work-from-home protocols for office workers. To support the well-being of our employees, we ensured that they continued to receive full pay during the initial weeks of facility closures, and, where closures were later extended in jurisdictions with weaker social safety nets, particularly in our Retail Branding and Information Solutions (“RBIS”) reportable segment, provided longer periods of salary continuation.
To meet our customer needs during periods of peak demand for label and packaging materials in North America and Europe, we took a number of steps to reduce backlogs, including leveraging our operational excellence to maximize production capacity, providing pay premiums for certain hourly employees, and temporarily allocating a portion of coating assets that normally support our graphics business to manufacture material for labels.
Overall, we have experienced negligible disruptions to our supply chain. As the largest customer for many of our suppliers, we have been able to secure continuity of material supply, while benefitting from our global footprint with dual sourcing for most commodities.
Overall, the pandemic has had a negative impact on our consolidated financial results year-to-date. Net sales for the second quarter of 2020 were down approximately 15% from the same period last year. However, we experienced sequential improvement in the third quarter of 2020, with our net sales for the period down approximately 2% from the same period last year, which was significantly better than we anticipated at the start of the quarter. While our label and packaging materials largely serve essential categories and experienced higher demand as a result of the pandemic in mid-March through May, demand slowed late in the second quarter and moderated in the third quarter. Sales of graphics products as well as sales in our RBIS reportable segment declined significantly in April due to lower demand, though we experienced sequential improvement during the rest of the second quarter and the third quarter. Additionally, sales in our Industrial and Healthcare Materials (“IHM”) reportable segment declined significantly in the second quarter mainly due to reduced industrial demand, particularly in automotive end markets, although we experienced sequential improvement in the third quarter.
We expect that the pandemic will have a negative impact for the fourth quarter and full year 2020. While we experienced sequential improvements in the third quarter of 2020, demand is lower across our businesses. We are unable to predict the full impact that COVID-19 will have on our results from operations, financial condition, liquidity and cash flows due to numerous uncertainties, including the duration and severity of the pandemic and containment measures and the related macroeconomic impacts. We are actively managing this dynamic environment and have updated our scenario planning to reflect the unique aspects of the pandemic.
19
We have continued to execute various long-term productivity and temporary cost saving actions to manage the downturn. These have included deferrals of planned compensation increases, hiring freezes, overtime and temporary labor reductions, shift reductions and furloughs, temporary production shutdowns, and travel and other discretionary spending reductions. While our balance sheet is strong and we have ample liquidity, during the first quarter of 2020, we drew down $500 million under our $800 million revolving credit facility (“Revolver”) because commercial paper markets were temporarily unavailable as a result of the pandemic. During the second quarter, we were able to access commercial paper markets and repaid the entire $500 million we had drawn down from our Revolver. Additionally, we have curtailed a portion of our planned capital spending for 2020, while protecting our long-term investments in high value product categories, and have heightened our focus on working capital management. We temporarily paused repurchasing shares during the second quarter of 2020 and resumed repurchases late in the third quarter of 2020. In the initial stages of the pandemic, we maintained our dividend rate; in October, we increased the rate by approximately 7%. We expect that our current cash and cash equivalents and the cash flows generated from operations will be sufficient to meet our operating requirements through this downturn.
We continue to actively monitor the COVID-19 situation and may take further actions that alter our business operations as may be required by federal, state or local authorities or that we determine are in the best interests of our employees, customers, suppliers and shareholders.
Net Sales
The factors impacting reported net sales change, as compared to the prior-year period, are shown in the table below.
Three Months Ended |
| Nine Months Ended |
| ||
| September 26, 2020 |
| September 26, 2020 |
| |
Reported sales change | (2) | % | (6) | % | |
Foreign currency translation | 1 | 2 | |||
Sales change ex. currency(1) | (1) | (4) | |||
Acquisitions | (2) | (2) | |||
Organic sales change(1) | (4) | % | (6) | % |
(1)Totals may not sum due to rounding
In the three and nine months ended September 26, 2020, net sales decreased on an organic basis compared to the same period in the prior year primarily due to the impact of COVID-19 on our markets and customers.
Net Income
Net income increased from approximately $141 million in the first nine months of 2019 to approximately $364 million for the first nine months of 2020. Major factors affecting the change in net income included the following:
● | Prior-year settlement loss from U.S. pension plan termination |
● | Benefits from productivity initiatives , including temporary cost reduction actions, and savings from restructuring actions, net of transition costs |
● | Net impact of pricing and raw material input costs |
Offsetting factors:
● | Lower sales primarily due to the impact of COVID-19 |
● | Higher restructuring charges |
● | Increased allowance for credit losses primarily as a result of COVID-19 |
● | Impact of foreign currency translation |
20
Acquisition
On February 28, 2020, we completed the acquisition of Smartrac’s Transponder (RFID Inlay) division (“Smartrac”), a manufacturer of radio-frequency identification (“RFID”) products, for consideration of approximately $255 million (€238 million). We believe this acquisition enhances our research and development capabilities, expands our product lines, and provides added manufacturing capacity. Consistent with the time allowed to complete our assessment, our valuation of certain acquired assets and liabilities, including environmental liabilities and income taxes, is preliminary. This acquisition was not material to our unaudited Condensed Consolidated Financial Statements.
Cost Reduction Actions
2019/2020 Actions
During the nine months ended September 26, 2020, we recorded $52.7 million in restructuring charges related to our 2019/2020 actions. These charges consisted of severance and related costs for the reduction of approximately 2,050 positions at numerous locations across our company, which primarily included actions in our Label and Graphic Materials (“LGM”) and RBIS reportable segments. The actions in LGM were primarily associated with the consolidation of our graphics business in Europe, in part in response to COVID-19. The actions in RBIS were primarily related to global headcount and footprint reduction, with some actions accelerated and expanded in response to COVID-19.
Restructuring charges were included in “Other expense (income), net” in the unaudited Condensed Consolidated Statements of Income. Refer to Note 6, “Cost Reduction Actions,” to the unaudited Condensed Consolidated Financial Statements for more information.
U.S. Pension Plan Termination
In connection with its termination in 2019, we settled approximately $753 million of liabilities of the Avery Dennison Pension Plan (the “ADPP”) by entering into an agreement to purchase annuities primarily from American General Life Insurance Company and through a combination of annuities and direct funding to the Pension Benefit Guaranty Corporation for a small portion of former employees and their beneficiaries.
Accounting Guidance Update
Refer to Note 1, “General,” to the unaudited Condensed Consolidated Financial Statements for this information.
Cash Flow
Nine Months Ended | ||||||
(In millions) |
| September 26, 2020 |
| September 28, 2019 | ||
Net cash provided by operating activities | $ | 441.8 | $ | 467.0 | ||
Purchases of property, plant and equipment |
| (91.7) |
| (132.9) | ||
Purchases of software and other deferred charges |
| (13.8) |
| (27.4) | ||
Proceeds from sales of property, plant and equipment |
| .2 |
| 7.7 | ||
Proceeds from insurance and sales (purchases) of investments, net |
| 5.2 |
| 3.5 | ||
Contributions for U.S. pension plan termination |
| — |
| 9.5 | ||
Free cash flow | $ | 341.7 | $ | 327.4 |
During the first nine months of 2020, net cash provided by operating activities decreased compared to the same period last year primarily due to changes in operational working capital, partially offset by lower payroll and incentive compensation payments, lower pension plan contributions, and lower severance payments related to restructuring actions. During the first nine months of 2020, free cash flow increased compared to the same period last year primarily due to a decrease in purchases of property, plant and equipment and reduced purchases of software and other deferred charges, partially offset by a decrease in net cash provided by operating activities and lower proceeds from sales of property, plant and equipment.
21
Outlook
Certain factors that we believe may contribute to our 2020 results are described below:
● | We expect net sales to decline as a result of COVID-19, although the amount of the decline is uncertain at this time. |
● | We anticipate partially offsetting the negative impact of COVID-19 on volume with approximately $150 million of net temporary cost savings. |
● | We estimate restructuring charges of approximately $60 million, including asset impairment charges recognized during the first nine months of 2020. |
● | We anticipate incremental savings from restructuring actions, net of transition costs, of $60 million to $70 million. |
● | We expect our full year effective tax rate to be approximately 24%. |
● | Based on recent foreign currency exchange rates, we expect foreign currency translation to reduce our net sales by approximately 1% and our operating income by approximately $9 million. |
● | We anticipate capital and software expenditures of $165 million to $175 million. |
ANALYSIS OF RESULTS OF OPERATIONS FOR THE THIRD QUARTER
Income Before Taxes
Three Months Ended |
| ||||||
(In millions, except percentages) |
| September 26, 2020 |
| September 28, 2019 | |||
Net sales | $ | 1,729.1 | $ | 1,761.4 | |||
Cost of products sold |
| 1,244.9 |
| 1,289.7 | |||
Gross profit |
| 484.2 |
| 471.7 | |||
Marketing, general and administrative expense |
| 258.3 |
| 265.3 | |||
Other expense (income), net |
| 12.4 |
| 6.7 | |||
Interest expense |
| 15.6 |
| 19.0 | |||
Other non-operating expense (income), net |
| .1 |
| .8 | |||
Income before taxes | $ | 197.8 | $ | 179.9 | |||
Gross profit margin |
| 28.0 | % |
| 26.8 | % |
Gross Profit Margin
Gross profit margin for the third quarter of 2020 increased compared to the same period last year primarily reflecting benefits from productivity initiatives, including temporary cost reduction actions, material re-engineering and savings from restructuring actions, net of transition costs, and the net benefit of pricing and raw material input costs, partially offset by the impact of lower volume and unfavorable product mix.
Marketing, General and Administrative Expense
Marketing, general and administrative expense decreased in the third quarter of 2020 compared to the same period last year primarily due to benefits from productivity initiatives, including temporary cost reduction actions,and savings from restructuring actions, net of transition costs, partially offset by higher employee-related costs.
22
Other Expense (Income), Net
Three Months Ended | ||||||
(In millions) |
| September 26, 2020 |
| September 28, 2019 | ||
Other expense (income), net, by type |
|
|
|
| ||
Restructuring charges: |
|
|
|
| ||
Severance and related costs | $ | 6.5 | $ | 3.3 | ||
Asset impairment charges |
| 4.4 |
| — | ||
Other items: |
|
|
| |||
Loss on investment |
| 1.5 |
| — | ||
Legal settlement |
| — |
| 3.4 | ||
Other expense (income), net | $ | 12.4 | $ | 6.7 |
Refer to Note 6, “Cost Reduction Actions,” to the unaudited Condensed Consolidated Financial Statements for more information regarding restructuring charges.
Interest Expense
Interest expense decreased in the third quarter of 2020 compared to the same period last year primarily reflecting lower borrowing rates from recently issued long-term debt.
Other Non-Operating Expense (Income), Net
Other non-operating expense decreased in the third quarter of 2020 compared to the same period last year primarily due to lower pension costs.
Net Income and Earnings per Share
Three Months Ended | |||||||
(In millions, except per share amounts and percentages) |
| September 26, 2020 |
| September 28, 2019 | |||
Income before taxes | $ | 197.8 | $ | 179.9 | |||
Provision for (benefit from) income taxes |
| 46.3 |
| 34.6 | |||
Equity method investment (losses) gains |
| (1.0) |
| (.7) | |||
Net income | $ | 150.5 | $ | 144.6 | |||
Per share amounts: |
|
| |||||
Net income per common share | $ | 1.80 | $ | 1.72 | |||
Net income per common share, assuming dilution |
| 1.79 |
| 1.71 | |||
Effective tax rate |
| 23.4 | % |
| 19.2 | % |
Provision for (Benefit from) Income Taxes
Our effective tax rate for the three months ended September 26, 2020 was 23.4% compared to 19.2% in the same period last year. The tax rate increase was primarily due to higher discrete benefits related to effective settlements of certain foreign tax audits in 2019. Refer to Note 8, “Taxes Based on Income,” to the unaudited Condensed Consolidated Financial Statements for more information.
23
RESULTS OF OPERATIONS BY REPORTABLE SEGMENT FOR THE THIRD QUARTER
Operating income refers to income before taxes, interest and other non-operating expense (income), net.
Label and Graphic Materials
Three Months Ended | ||||||
(In millions) |
| September 26, 2020 |
| September 28, 2019 | ||
Net sales including intersegment sales | $ | 1,165.2 | $ | 1,203.3 | ||
Less intersegment sales |
| (19.8) |
| (18.2) | ||
Net sales | $ | 1,145.4 | $ | 1,185.1 | ||
Operating income(1) |
| 173.1 |
| 159.0 | ||
(1)Included charges associated with restructuring actions in both years | $ | 1.4 | $ | 1.2 |
Net Sales
The factors impacting reported net sales change are shown in the table below.
| Three Months Ended | ||
September 26, 2020 | |||
Reported sales change |
| (3) | % |
Foreign currency translation |
| 1 | |
Sales change ex. currency(1) | (3) | ||
Acquisitions | — | ||
Organic sales change(1) |
| (3) | % |
(1)Totals may not sum due to rounding
In the third quarter of 2020, net sales decreased on an organic basis compared to the same period in the prior year primarily due to unfavorable volume/mix and raw material deflation-related price reductions. On an organic basis, net sales were comparable in emerging markets, increased by a low-single digit rate in North America and decreased by approximately 10% in Western Europe.
Operating Income
Operating income increased in the third quarter of 2020 compared to the same period last year primarily due to benefits from productivity initiatives, including temporary cost reduction actions, material re-engineering, and savings from restructuring actions, net of transition costs, as well as, benefits from raw material deflation, net of pricing, partially offset by higher employee-related costs and unfavorable volume/mix.
Retail Branding and Information Solutions
Three Months Ended | ||||||
(In millions) |
| September 26, 2020 |
| September 28, 2019 | ||
Net sales including intersegment sales | $ | 433.4 | $ | 412.4 | ||
Less intersegment sales |
| (7.3) |
| (5.6) | ||
Net sales | $ | 426.1 | $ | 406.8 | ||
Operating income(1) |
| 47.0 |
| 45.7 | ||
(1)Included charges associated with restructuring actions in both years and loss on investment in 2020 | $ | 4.4 | $ | 1.2 |
24
Net Sales
The factors impacting reported net sales change are shown in the table below.
| Three Months Ended | ||
September 26, 2020 |
| ||
Reported sales change |
| 5 | % |
Foreign currency translation |
| 1 | |
Sales change ex. currency(1) | 5 | ||
Acquisitions | (10) | ||
Organic sales change(1) |
| (5) | % |
(1)Totals may not sum due to rounding
In the third quarter of 2020, net sales increased ex. currency compared to the same period in the prior year due to approximately 65 % increase in sales of RFID solutions in the segment, including the benefit of the Smartrac acquisition, partially offset by an approximately 12% decline in the base business due to lower demand for apparel. The substantial majority of our sales of RFID solutions are reported within our RBIS reportable segment. On an organic basis, net sales in the segment related to RFID solutions increased by a high-teens rate. Company-wide, sales of RFID solutions increased on an organic basis by approximately 20%.
Operating Income
Operating income increased in the third quarter of 2020 compared to the same period last year primarily due to benefits from productivity initiatives, including temporary cost reduction actions, and savings from restructuring actions, net of transition costs, partially offset by lower volume.
Industrial and Healthcare Materials
Three Months Ended | ||||||
(In millions) |
| September 26, 2020 |
| September 28, 2019 | ||
Net sales including intersegment sales | $ | 159.6 | $ | 171.0 | ||
Less intersegment sales |
| (2.0) |
| (1.5) | ||
Net sales | $ | 157.6 | $ | 169.5 | ||
Operating income(1) |
| 12.5 |
| 17.7 | ||
(1)Included charges associated with restructuring in both years | $ | 6.6 | $ | .9 |
Net Sales
The factors impacting reported net sales change are shown in the table below.
| Three Months Ended | ||
September 26, 2020 |
| ||
Reported sales change |
| (7) | % |
Foreign currency translation |
| (1) | |
Sales change ex. currency(1) | (8) | ||
Acquisitions | — | ||
Organic sales change(1) |
| (8) | % |
(1)Totals may not sum due to rounding
In the third quarter of 2020, net sales decreased on an organic basis compared to the same period in the prior year primarily due to a mid-single digit decline in industrial categories and an approximately 11% decline in healthcare categories.
Operating Income
Operating income decreased in the third quarter of 2020 compared to the same period last year primarily due to lower volume and higher restructuring charges, partially offset by benefits from productivity initiatives, including temporary cost reduction actions and savings from restructuring actions, net of transition costs, as well as favorable product mix.
25
ANALYSIS OF RESULTS OF OPERATIONS FOR THE NINE MONTHS YEAR-TO-DATE
Income Before Taxes
Nine Months Ended |
| ||||||
(In millions, except percentages) |
| September 26, 2020 |
| September 28, 2019 |
| ||
Net sales | $ | 4,980.6 | $ | 5,297.2 | |||
Cost of products sold |
| 3,628.4 |
| 3,877.8 | |||
Gross profit |
| 1,352.2 |
| 1,419.4 | |||
Marketing, general and administrative expense |
| 758.7 |
| 807.3 | |||
Other expense (income), net |
| 57.3 |
| 21.7 | |||
Interest expense |
| 54.4 |
| 58.0 | |||
Other non-operating expense (income), net |
| (.2) |
| 448.2 | |||
Income before taxes | $ | 482.0 | $ | 84.2 | |||
Gross profit margin |
| 27.1 | % |
| 26.8 | % |
Gross Profit Margin
Gross profit margin for the first nine months of 2020 increased from the same period last year primarily reflecting the benefit of pricing and raw material input costs and benefits from productivity initiatives, including temporary cost reduction actions, material re-engineering and savings from restructuring actions, net of transition costs, partially offset by reduced fixed cost leverage and unfavorable product mix.
Marketing, General and Administrative Expense
Marketing, general and administrative expense decreased in the first nine months of 2020 compared to the same period last year primarily due to benefits from productivity initiatives, including temporary cost reduction actions, and savings from restructuring actions, net of transition costs, as well as, favorable foreign currency translation, partially offset by the impact of the Smartrac acquisition and increased allowance for credit losses.
Other Expense (Income), Net
Nine Months Ended | ||||||
(In millions) |
| September 26, 2020 |
| September 28, 2019 | ||
Other expense (income), net, by type |
|
|
|
| ||
Restructuring charges: |
|
|
|
| ||
Severance and related costs | $ | 46.4 | $ | 19.8 | ||
Asset impairment charges and lease cancellation costs |
| 6.2 |
| 1.7 | ||
Other items: |
|
|
| |||
Loss on investment | 1.5 | — | ||||
Transaction and related costs |
| 3.2 |
| — | ||
Legal settlement | — | 3.4 | ||||
Gain on sales of assets |
| — |
| (3.2) | ||
Other expense (income), net | $ | 57.3 | $ | 21.7 |
Refer to Note 6, “Cost Reduction Actions,” to the unaudited Condensed Consolidated Financial Statements for more information regarding restructuring charges.
Interest Expense
Interest expense decreased in the first nine months of 2020 compared to the same period last year reflecting lower borrowing rates on our outstanding indebtedness, partially offset by fees paid for borrowings under the Revolver.
26
Other Non-Operating Expense (Income), Net
Other non-operating expense decreased in the first nine months of 2020 compared to the same period last year primarily due to the prior year impact of the ADPP termination.
Net Income and Earnings per Share
Nine Months Ended |
| ||||||
(In millions, except per share amounts and percentages) |
| September 26, 2020 |
| September 28, 2019 |
| ||
Income before taxes | $ | 482.0 | $ | 84.2 | |||
Provision for (benefit from) income taxes |
| 114.8 |
| (58.9) | |||
Equity method investment (losses) gains |
| (2.8) |
| (2.0) | |||
Net income | $ | 364.4 | $ | 141.1 | |||
Per share amounts: |
|
| |||||
Net income per common share | $ | 4.37 | $ | 1.68 | |||
Net income per common share, assuming dilution |
| 4.34 |
| 1.66 | |||
Effective tax rate |
| 23.8 | % |
| (70.0) | % |
Provision for (Benefit from) Income Taxes
Our effective tax rate for the nine months ended September 26, 2020 was 23.8% compared to (70.0)% in the same period last year. The change in tax rate was due to the tax benefits from the settlement charges associated with the termination of the ADPP in the nine months ended September 28, 2019. Refer to Note 8, “Taxes Based on Income,” to the unaudited Condensed Consolidated Financial Statements for more information.
We estimate our effective tax rate for fiscal year 2020 to be approximately 24%. Our effective tax rate can vary from quarter to quarter due to a variety of factors, such as changes in the mix of earnings in countries with differing statutory tax rates, changes in tax reserves, settlements of income tax audits, changes in tax laws and regulations, return-to-provision adjustments, tax impacts related to stock-based payments and execution of tax planning strategies. We do not currently expect our effective tax rate to be significantly impacted by COVID-19. However, this expectation may change if the duration or severity of COVID-19 is longer or more detrimental than currently estimated.
We continue to pursue planning opportunities in certain foreign jurisdictions primarily to react to the loss of concessionary tax rates. We believe that we are on track to realize these opportunities. We continue to evaluate factors that may significantly influence the amount of benefit to be recognized in fiscal year 2020.
RESULTS OF OPERATIONS BY REPORTABLE SEGMENT FOR THE NINE MONTHS YEAR-TO-DATE
Operating income refers to income before taxes, interest and other non-operating expense (income), net.
Label and Graphic Materials
Nine Months Ended | ||||||
(In millions) |
| September 26, 2020 |
| September 28, 2019 | ||
Net sales including intersegment sales | $ | 3,475.5 | $ | 3,629.2 | ||
Less intersegment sales |
| (55.1) |
| (59.5) | ||
Net sales | $ | 3,420.4 | $ | 3,569.7 | ||
Operating income(1) |
| 483.1 |
| 460.6 | ||
(1)Included charges associated with restructuring actions in both years, transaction and related costs in 2020, and gain on sale of assets in 2019 | $ | 28.3 | $ | 13.2 |
27
Net Sales
The factors impacting reported net sales change are shown in the table below.
| Nine Months Ended | ||
September 26, 2020 | |||
Reported sales change |
| (4) | % |
Foreign currency translation |
| 2 | |
Sales change ex. currency(1) |
| (2) | |
Acquisitions | — | ||
Organic sales change(1) |
| (2) | % |
(1) Totals may not sum due to rounding
In the first nine months of 2020, net sales decreased on an organic basis compared to the same period in the prior year due to the combined effects of lower volume/mix and raw material deflation-related price reductions. On an organic basis, net sales decreased by a low-single digit rate in emerging markets, increased by a low-single digit rate in North America and decreased by a mid-single digit rate in Western Europe.
Operating Income
Operating income increased in the first nine months of 2020 compared to the same period last year primarily due to benefits from productivity initiatives, including temporary cost reduction actions, material re-engineering and savings from restructuring actions, net of transition costs, as well as, benefits from raw material deflation, net of pricing. These benefits were partially offset by unfavorable volume/mix, higher restructuring charges, unfavorable foreign currency translation, increased allowance for credit losses and higher employee-related costs.
Retail Branding and Information Solutions
Nine Months Ended | ||||||
(In millions) |
| September 26, 2020 |
| September 28, 2019 | ||
Net sales including intersegment sales | $ | 1,142.3 | $ | 1,238.2 | ||
Less intersegment sales |
| (19.4) |
| (14.8) | ||
Net sales | $ | 1,122.9 | $ | 1,223.4 | ||
Operating income(1) |
| 67.2 |
| 147.5 | ||
(1)Included charges associated with restructuring actions in both years, transaction and related costs and loss on investment in 2020, and gain on sale of assets in 2019 | $ | 20.6 | $ | .9 |
Net Sales
The factors impacting reported net sales change are shown in the table below.
| Nine Months Ended |
| |
September 26, 2020 |
| ||
Reported sales change |
| (8) | % |
Foreign currency translation |
| 1 | |
Sales change ex. currency(1) | (7) | ||
Acquisitions |
| (7) | |
Organic sales change(1) |
| (14) | % |
(1) Totals may not sum due to rounding
In the first nine months of 2020, net sales decreased ex. currency compared to the same period in the prior year due to an approximately 20% decline in the base business driven by temporary closures of apparel manufacturing sites and lower demand for apparel, partially offset by a nearly 30% increase in RFID solutions in the segment including the benefit of the Smartrac acquisition. The substantial majority of our sales of RFID solutions are reported within our RBIS reportable segment. On an organic basis, sales in the segment
28
related to RFID solutions increased by a low-single digit rate. Company-wide, sales of RFID solutions increased on an organic basis at a mid-single digit rate.
Operating Income
Operating income decreased in the first nine months of 2020 compared to the same period last year primarily due to lower volume, higher long-term growth-related investments, including costs associated with the Smartrac acquisition, higher restructuring charges and increased allowance for credit losses, partially offset by benefits from productivity initiatives, including temporary cost reduction actions and savings from restructuring actions, net of transition costs, as well as lower raw material costs and lower employee-related costs.
Industrial and Healthcare Materials
Nine Months Ended | ||||||
(In millions) |
| September 26, 2020 |
| September 28, 2019 | ||
Net sales including intersegment sales | $ | 442.1 | $ | 511.1 | ||
Less intersegment sales |
| (4.8) |
| (7.0) | ||
Net sales | $ | 437.3 | $ | 504.1 | ||
Operating income(1) |
| 34.9 |
| 47.8 | ||
(1)Included charges associated with restructuring in both years | $ | 8.6 | $ | 4.2 |
Net Sales
The factors impacting reported net sales change are shown in the table below.
| Nine Months Ended |
| |
September 26, 2020 |
| ||
Reported sales change |
| (13) | % |
Foreign currency translation |
| 1 | |
Sales change ex. currency(1) | (12) | ||
Acquisitions | — | ||
Organic sales change(1) |
| (12) | % |
(1) Totals may not sum due to rounding
In the first nine months of 2020, net sales decreased on an organic basis compared to the same period in the prior year primarily due to a mid-teens rate decline in industrial categories and a mid-single digit decline in healthcare categories.
Operating Income
Operating income decreased in the first nine months of 2020 compared to the same period last year primarily due to lower volume and higher restructuring charges, partially offset by benefits from productivity initiatives, including temporary cost reduction actions and savings from restructuring actions, net of transition costs.
29
FINANCIAL CONDITION
Liquidity
Operating Activities
Nine Months Ended | ||||||
(In millions) |
| September 26, 2020 |
| September 28, 2019 | ||
Net income | $ | 364.4 | $ | 141.1 | ||
Depreciation |
| 113.7 |
| 105.3 | ||
Amortization | 36.1 | 28.1 | ||||
Provision for credit losses and sales returns |
| 50.4 |
| 42.4 | ||
Stock-based compensation |
| 12.1 |
| 25.5 | ||
Pension plan settlements and related charges |
| — |
| 446.9 | ||
Deferred taxes and other non-cash taxes |
| 17.1 |
| (176.4) | ||
Other non-cash expense and loss (income and gain), net |
| 35.3 |
| 17.5 | ||
Changes in assets and liabilities and other adjustments |
| (187.3) |
| (163.4) | ||
Net cash provided by operating activities | $ | 441.8 | $ | 467.0 |
During the first nine months of 2020, net cash provided by operating activities decreased compared to the same period last year primarily due to changes in operational working capital, partially offset by lower payroll and incentive compensation payments, lower pension plan contributions, and lower severance payments related to restructuring actions.
Investing Activities
Nine Months Ended | ||||||
(In millions) |
| September 26, 2020 |
| September 28, 2019 | ||
Purchases of property, plant and equipment | $ | (91.7) | $ | (132.9) | ||
Purchases of software and other deferred charges |
| (13.8) |
| (27.4) | ||
Proceeds from sales of property, plant and equipment |
| .2 |
| 7.7 | ||
Proceeds from insurance and sales (purchases) of investments, net |
| 5.2 |
| 3.5 | ||
Payments for acquisition, net of cash acquired, and investments in businesses |
| (262.8) |
| (6.5) | ||
Net cash used in investing activities | $ | (362.9) | $ | (155.6) |
Purchases of Property, Plant and Equipment
During the first nine months of 2020 and 2019, we invested in equipment to support growth in North America, Asia and Europe and to improve manufacturing productivity.
Purchases of Software and Other Deferred Charges
During the first nine months of 2020 and 2019, we invested in information technology upgrades worldwide. During the first nine months of 2019, we also invested in enterprise resource planning system implementations in North America.
Proceeds from Sales of Property, Plant and Equipment
During the first nine months of 2019, the majority of the proceeds from sales of property, plant and equipment was related to the sale of three properties in North America, Asia and Europe.
Proceeds from Insurance and Sales (Purchases) of Investments, Net
During the first nine months of 2020, we had lower net purchases of investments and lower proceeds from insurance associated with our corporate-owned life insurance policies compared to the same period last year.
30
Payments for Acquisition, Net of Cash Acquired, and Investments in Businesses
During the first nine months of 2020, we paid consideration, net of cash acquired, of approximately $255 million to acquire Smartrac, which we initially funded through commercial paper borrowings, and we invested in certain strategic unconsolidated businesses. During the first nine months of 2019, we made investments in certain strategic unconsolidated businesses.
Financing Activities
Nine Months Ended | ||||||
(In millions) |
| September 26, 2020 |
| September 28, 2019 | ||
Net increase (decrease) in borrowings (maturities of three months or less) | $ | (57.1) | $ | 68.9 | ||
Additional borrowings under revolving credit facility | 500.0 | — | ||||
Repayments of revolving credit facility | (500.0) | — | ||||
Additional long-term borrowings | 493.7 | — | ||||
Repayments of long-term debt and finance leases |
| (268.9) |
| (17.7) | ||
Dividends paid |
| (145.2) |
| (141.3) | ||
Share repurchases |
| (52.2) |
| (204.3) | ||
Net (tax withholding) proceeds related to stock-based compensation |
| (20.0) |
| (17.4) | ||
Payments of contingent consideration |
| — |
| (1.6) | ||
Net cash used in financing activities | $ | (49.7) | $ | (313.4) |
Borrowings and Repayment of Debt
Given the seasonality of our cash flow from operating activities, during the first nine months of 2020 and 2019, our commercial paper borrowings were used to fund dividend payments, share repurchases, and capital expenditures, and for other general corporate purposes. During the first quarter of 2020, commercial paper borrowings were also used to fund the Smartrac acquisition, with those borrowings subsequently repaid using the net proceeds of $493.7 million from the $500 million of senior notes we issued in March 2020. We used the remaining proceeds from these notes to repay the $250 million aggregate principal amount of senior notes that matured in April 2020. In the second quarter of 2020, we also repaid $15 million of medium-term notes that matured in June 2020.
In the first quarter of 2020, in light of uncertainty as a result of COVID-19 regarding the availability of commercial paper, which we typically rely upon to fund our day-to-day operational needs, and the relatively favorable terms under our recently-extended $800 million Revolver, we borrowed $500 million from the Revolver with a six-month duration. This amount was repaid in June 2020.
Refer to Note 4, “Debt” to the unaudited Condensed Consolidated Financial Statements for more information.
Dividends Paid
We paid dividends of $1.74 per share in the first nine months of 2020 compared to $1.68 per share in the same period last year. In April 2019, we increased our quarterly dividend to $.58 per share, representing an increase of approximately 12% from our previous dividend rate of $.52 per share. In October 2020, we increased our quarterly dividend to $.62, representing an increase of approximately 7%.
Share Repurchases
During the first nine months of 2020 and 2019, we repurchased approximately .4 million and 2 million shares of our common stock, respectively. In the first quarter of 2020, we temporarily paused share repurchase activity as a result of COVID-19. We resumed the repurchase of shares late in the third quarter of 2020.
Analysis of Selected Balance Sheet Accounts
Long-lived Assets
In the nine months ended September 26, 2020, goodwill increased by approximately $129 million to $1.06 billion, which reflected the preliminary valuation of goodwill associated with the Smartrac acquisition and the impact of foreign currency translation.
In the nine months ended September 26, 2020, other intangibles resulting from business acquisitions, net, increased by approximately $68 million to $194.1 million, which reflected the valuation of other intangibles from the Smartrac acquisition and the impact of foreign currency translation, partially offset by current year amortization expense.
31
Refer to Note 3, “Goodwill and Other Intangibles Resulting from Business Acquisitions,” to the unaudited Condensed Consolidated Financial Statements for more information.
Shareholders’ Equity Accounts
As of September 26, 2020, the balance of our shareholders’ equity was $1.33 billion. Refer to Note 10, “Supplemental Equity and Comprehensive Income Information,” to the unaudited Condensed Consolidated Financial Statements for more information.
Impact of Foreign Currency Translation
Nine Months Ended | |||
(In millions) |
| September 26, 2020 | |
Change in net sales | $ | (103) |
International operations generated approximately 75% of our net sales during the nine months ended September 26, 2020. Our future results are subject to changes in political and economic conditions in the regions in which we operate and the impact of fluctuations in foreign currency exchange and interest rates.
The unfavorable impact of foreign currency translation on net sales in the first nine months of 2020 compared to the same period last year was primarily related to sales in Brazil and China, euro-denominated sales, and sales in India.
Effect of Foreign Currency Transactions
The impact on net income from transactions denominated in foreign currencies is largely mitigated because the costs of our products are generally denominated in the same currencies in which they are sold. In addition, to reduce our income and cash flow exposure to transactions in foreign currencies, we enter into foreign exchange forward, option and swap contracts where available and appropriate. Refer to Note 7, “Financial Instruments,” to the unaudited Condensed Consolidated Financial Statements for more information.
Analysis of Selected Financial Ratios
We utilize the financial ratios discussed below to assess our financial condition and operating performance. We believe this information assists our investors in understanding drivers of our cash flow other than net income and capital expenditures.
Operational Working Capital Ratio
Operational working capital, as a percentage of annualized current-quarter net sales, is reconciled to working capital below. Our objective is to minimize our investment in operational working capital, as a percentage of annualized current-quarter net sales, to maximize cash flow and return on investment. Operational working capital, as a percentage of annualized current-quarter net sales, in the third quarter of 2020, was higher compared to the third quarter of 2019.
(In millions, except percentages) |
| September 26, 2020 |
| September 28, 2019 | |||
(A) Working capital | $ | 558.5 | $ | 65.5 | |||
Reconciling items: |
|
| |||||
Cash and cash equivalents |
| (284.7) |
| (224.2) | |||
Other current assets |
| (214.5) |
| (220.0) | |||
Short-term borrowings and current portion of long-term debt and finance leases | 124.1 | 514.2 | |||||
Accrued payroll and employee benefits and other current liabilities |
| 759.1 |
| 712.5 | |||
(B) Operational working capital | $ | 942.5 | $ | 848.0 | |||
(C) Third-quarter net sales, annualized | $ | 6,916.4 | $ | 7,045.6 | |||
Operational working capital, as a percentage of annualized current-quarter net sales: (B) ÷ (C) |
| 13.6 | % |
| 12.0 | % |
32
Accounts Receivable Ratio
The average number of days sales outstanding was 65 days in the first nine months of 2020 compared to 63 days in the first nine months of 2019, calculated using the average of the three quarter-end trade accounts receivable balances divided by the average daily sales for the first nine months. The increase in the average number of days sales outstanding primarily reflected the impact of COVID-19 on sales, partially offset by focused collection results.
Inventory Ratio
Average inventory turnover was 6.9 in the first nine months of 2020 compared to 7.7 in the first nine months of 2019, calculated using the annualized cost of sales (year-to-date cost of products sold, divided by three and multiplied by four) divided by the three-quarter average inventory balance at quarter-end. The decrease in average inventory turnover primarily reflected lower cost of products sold due to lower volume and inventory build to meet unpredictable customer demands, both as a result of COVID-19, partially offset by focused efforts to optimize inventory balances relative to demand.
Accounts Payable Ratio
The average number of days payable outstanding was 73 days in the first nine months of 2020 compared to 74 days in the first nine months of 2019, calculated using the three-quarter average accounts payable balance divided by the average daily cost of products sold for the first nine months. The decrease in the average number of days payable outstanding from the prior year primarily reflected lower purchase levels related to inventory optimization efforts, partially offset by longer payment terms and the impact of foreign currency translation.
Capital Resources
Capital resources include cash flows from operations, cash and cash equivalents, and debt financing, including access to commercial paper supported by our Revolver. We use these resources to fund our operational needs. At September 26, 2020, we had cash and cash equivalents of $284.7 million held in accounts at third-party financial institutions.
Our cash balances are held in numerous locations throughout the world. At September 26, 2020, the majority of our cash and cash equivalents was held by our foreign subsidiaries.
To meet U.S. cash requirements, we have several cost-effective liquidity options available. These options include borrowing funds at reasonable rates, including borrowings from foreign subsidiaries, and repatriating foreign earnings and profits. However, if we were to repatriate incremental foreign earnings and profits, we may be subject to withholding taxes imposed by foreign tax authorities and additional U.S. taxes due to the impact of foreign currency movements related to these earnings and profits.
In February 2020, we amended and restated our $800 million Revolver, extending its maturity date to February 13, 2025. The maturity date may be extended for a one-year period under certain circumstances. The commitments under the Revolver may be increased by up to $400 million, subject to lender approvals and customary requirements. The Revolver is used as a back-up facility for our commercial paper program and can be used for other corporate purposes. In the first quarter of 2020, in light of the uncertainty regarding the availability of commercial paper, which we typically rely upon to fund our day-to-day operational needs, and the relatively favorable terms under the Revolver, we drew down $500 million from the Revolver with a six-month duration. This amount was repaid in June 2020. No balance was outstanding under the Revolver as of September 26, 2020 or December 28, 2019.
The Revolver contains a financial covenant that requires us to maintain a maximum leverage ratio (calculated as a ratio of consolidated debt to consolidated EBITDA as defined in the agreement) of not more than 3.50 to 1.00; provided that, in the event of an acquisition by us that exceeds $250 million, the maximum leverage ratio increases to 4.00 to 1.00 for the fiscal quarter in which the acquisition occurs and three consecutive fiscal quarters immediately following that fiscal quarter. As of September 26, 2020 and December 28, 2019, our ratio was substantially below the maximum ratio required by the Revolver.
In March 2020, we issued $500 million of senior notes, due April 2030. These senior notes bear an interest rate of 2.65% per year, payable semiannually in arrears. Our net proceeds from the offering, after deducting underwriting discounts and offering expenses, were $493.7 million, which we used to repay both existing indebtedness under our commercial paper program used to fund our Smartrac acquisition and our $250 million of senior notes that matured in April 2020.
In the second quarter of 2020, we also repaid $15 million of medium-term notes that matured in June 2020.
33
Capital from Debt
The carrying value of our total debt increased by approximately $205 million in the first nine months of 2020 to $2.14 billion, primarily reflecting the issuance of senior notes in March 2020, partially offset by long- and medium-term debt repayments in the second quarter of 2020 and a net decrease in commercial paper borrowings.
Credit ratings are a significant factor in our ability to raise short- and long-term financing. The credit ratings assigned to us also impact the interest rates we pay and our access to commercial paper, credit facilities, and other borrowings. A downgrade of our short-term credit ratings could impact our ability to access the commercial paper markets. If our access to commercial paper markets were to become limited, as it did in the first quarter of 2020 as a result of COVID-19, we believe that the Revolver and our other credit facilities would be available to meet our short-term funding requirements. When determining a credit rating, we believe that rating agencies primarily consider our competitive position, business outlook, consistency of cash flows, debt level and liquidity, geographic dispersion and management team. There has been no change to the credit ratings assigned to us as a result of COVID-19. We remain committed to maintaining an investment grade rating.
Off-Balance Sheet Arrangements, Contractual Obligations, and Other Matters
Refer to Note 12, “Commitments and Contingencies,” to the unaudited Condensed Consolidated Financial Statements for this information. Except as indicated therein, we have no material off-balance sheet arrangements as described in Item 303 (a)(4) of Regulation S-K.
RECENT ACCOUNTING REQUIREMENTS
Refer to Note 1, “General,” to the unaudited Condensed Consolidated Financial Statements for this information.
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
There have been no material changes to the information provided in Part II, Item 7A of our Annual Report on Form 10-K for the fiscal year ended December 28, 2019 that have not been disclosed in our periodic filings with the SEC.
ITEM 4. CONTROLS AND PROCEDURES
Evaluation of Disclosure Controls and Procedures
We maintain disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(f)) that are designed to ensure that information required to be disclosed in our Exchange Act reports is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding the required disclosure.
In designing and evaluating the disclosure controls and procedures, we recognize that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management necessarily is required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.
Our disclosure controls system is based upon a global chain of financial and general business reporting lines that converge in our headquarters in Glendale, California. As required by SEC Rule 13a-15(b), we carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures as of the end of the quarter covered by this report. Based on the foregoing, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures were effective as of such time to provide reasonable assurance that information was recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information was accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding the required disclosure.
34
Changes in Internal Control Over Financial Reporting
There were no changes in our internal control over financial reporting during the most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
35
PART II. OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS
Refer to “Legal Proceedings” in Note 12, “Commitments and Contingencies,” to the unaudited Condensed Consolidated Financial Statements in Part 1, Item 1 for this information.
ITEM 1A. RISK FACTORS
The risk factors described in this section further modify some of the risk factors described in our Annual Report on Form 10-K for the year ended December 28, 2019 filed with the Securities and Exchange Commission on February 26, 2020 and modified in our Quarterly Reports on Form 10-Q for the quarters ended March 28 and June 27, 2020 and could materially adversely affect our business, including our results of operations, cash flows and financial condition, and cause the value of our securities to decline. These risks and uncertainties have been, and will continue to be, impacted by the coronavirus/COVID-19 pandemic (collectively referred to herein as “COVID-19”) and any worsening of the global business and economic environment as a result. This list of risks is not exhaustive. Our ability to attain our goals and objectives is dependent on numerous factors and risks, including, but not limited to, the most significant ones described in our Annual Report on Form 10-K, as further modified by this and previous sections in our subsequent Quarterly Reports on From 10-Q.
COVID-19 has had an adverse effect on portions of our business and we could experience further negative consequences and/or materially adverse effects.
In late 2019, a novel strain of coronavirus emerged that has and is continuing to spread throughout the world, most extensively in the United States, India and Brazil. In January 2020, the World Health Organization declared this outbreak a “Public Health Emergency of International Concern,” and, in March 2020, the World Health Organization declared COVID-19 as a pandemic. Throughout 2020, governments in many countries, the vast majority of U.S. states and many cities and other jurisdictions have at various times and to varying degrees ordered their residents to cease traveling to non-essential jobs and to curtail all unnecessary travel, and to stay in their homes as much as possible.
Overall, the pandemic has had a negative impact on our consolidated financial results year-to-date. Total net sales for the second quarter of 2020 were down approximately 15% from the same period last year. However, we experienced sequential improvement in the third quarter of 2020, with our total net sales for the period down approximately 2% from the same period last year, which was significantly better than we anticipated at the start of the quarter. While our label and packaging materials largely serve essential categories and experienced higher demand as a result of the pandemic in mid-March through May, demand slowed late in the second quarter and moderated in the third quarter. Sales of graphics products as well as sales in our Retail Branding and Information Solutions (“RBIS”) reportable segment declined significantly in April due to lower demand, though we experienced sequential improvement during the rest of the second quarter and the third quarter. Additionally, sales in our Industrial and Healthcare Materials (“IHM”) reportable segment declined significantly in the second quarter mainly due to reduced industrial demand, particularly in automotive end markets, although we experienced sequential improvement in the third quarter.
We expect that the pandemic will have a negative impact for the fourth quarter and full year 2020. While we experienced sequential improvements in the third quarter of 2020, demand is lower across our businesses. We are unable to predict the full impact that COVID-19 will have on our results from operations, financial condition, liquidity and cash flows due to numerous uncertainties, including the duration and severity of the pandemic and containment measures and the related macroeconomic impacts. We are actively managing this dynamic environment and have updated our scenario planning to reflect the unique aspects of the pandemic.
The demand for our products is impacted by the effects of, and changes in, worldwide economic, social, political and market conditions, which could have a material adverse effect on our business.
We have operations in over 50 countries and our domestic and international operations are strongly influenced by matters beyond our control, including changes in political, social, economic and labor conditions, tax laws (including U.S. taxes on foreign earnings), and international trade regulations (including tariffs), as well as the impact of these changes on the underlying demand for our products. In 2019 and the first nine months of 2020, approximately 77% and 75%, respectively, of our sales were from international operations.
36
Macroeconomic developments such as impacts from COVID-19, slower growth in the geographic regions in which we operate, the restructuring of European sovereign and other debt obligations, the impact of the United Kingdom’s (“UK’s”) exit from the European Union on January 31, 2020 (commonly known as “Brexit”), and uncertainty in the global credit or financial markets leading to a loss of consumer confidence could result in a material adverse effect on our business as a result of, among other things, reduced consumer spending, declines in asset valuations, diminished liquidity and credit availability, volatility in securities prices, credit rating downgrades, and fluctuations in foreign currency exchange rates. Fluctuations in currencies, such as those associated with the euro, Chinese Yuan (renminbi), and Brazilian real in 2019, can result in a variety of negative effects, including lower net sales, increased costs, lower gross margin percentages, increased allowances for credit losses and/or write-offs of accounts receivable, and required recognition of impairments of capitalized assets, including goodwill and other intangibles. In particular, we expect foreign currency translation to reduce our operating income in 2020 by approximately $9 million.
We continue to face uncertainty with respect to trade relations between the U.S. and many of its trading partners. Over the past few years, the U.S. government has imposed additional tariffs on products imported into the U.S. This has resulted in reciprocal tariffs on goods imported from the U.S. into China, the European Union, Mexico, Canada, and certain other countries. The impacts on our operations to date have been insignificant although there was some volatility in the timing of purchases by the retailers served by our RBIS reportable segment in light of trade-related uncertainty during 2019. There remains a risk that our business could be significantly impacted if additional tariffs or other restrictions are imposed on products imported from these or other countries, or if relations with these countries more broadly deteriorate. These countries may continue to retaliate by imposing similar tariffs or restrictions on products imported from the U.S. Any of these actions or further developments in international trade relations could have a material adverse effect on our business.
In addition, business and operational disruptions or delays caused by political, social or economic instability and unrest – such as civil, political and economic disturbances in places such as the U.S., Russia, Ukraine, Syria, Iraq, Iran, Turkey, North Korea, Hong Kong, and Chile and the related impact on global stability, terrorist attacks and the potential for other hostilities, public health crises or natural disasters in various parts of the world – could contribute to a climate of economic and political uncertainty that in turn could have material adverse effects on our business. We are not able to predict the duration and severity of adverse economic, social, political or market conditions in the U.S. or other countries.
The ability of our employees to work may be significantly impacted by COVID-19.
Our employees have been affected by COVID-19. Our office and management personnel have continued generally working from home, and some of our employees engaged in manufacturing, production and distribution facilities were at times restricted by governmental orders from coming to work. We have experienced, and may experience in the future, temporary facility closures in response to government mandates in certain jurisdictions in which we operate. The safety, health and well-being of our employees are our top priorities and we may need to enact further precautionary measures to help minimize the risk of our workforce being exposed to COVID-19, including securing supplies for our facilities and providing personal protective equipment for our employees. Further, our management team is focused on mitigating the adverse economic effects of COVID-19, which has required and will continue to require a large investment of time and resources across our entire company, thereby diverting attention from other priorities that existed prior to the pandemic. If these conditions worsen, or last for an extended period of time, or there is a disruption in the technology we use to operate remotely, our management team’s ability to manage our business may be impaired, and operational, cybersecurity and other risks facing us prior to the pandemic may be elevated.
We cannot predict the impact of COVID-19 on our customers, suppliers, vendors, and other business partners, including our financing sources.
COVID-19 is affecting our customers, suppliers, vendors, and other business partners, but we are not able to predict the ultimate consequences that will result. Delays in production or delivery of components or raw materials in our global supply chain, or the ability to transport those components or materials or our finished goods, due to restrictions imposed to limit the spread of COVID-19 could delay or inhibit our ability to obtain supply of components and materials to deliver finished goods to customers. While disruptions to our supply chain during the first three quarters were not significant, if current conditions worsen or last for an extended period of time, our supply chains could be materially adversely affected. If our sales channels are substantially impaired for an extended period of time, our business could be materially adversely affected. In the first quarter, our ability to access the commercial paper market was disrupted. If this source of financing or our ability to draw under our $800 million revolving credit facility were disrupted in the future, our liquidity could be adversely affected.
37
Our growth strategy includes increased concentration in emerging markets, including China, which could create greater exposure to unstable political conditions, civil unrest, economic volatility, contagious disease and other risks applicable to international operations.
A significant amount of our sales is derived from emerging markets, including countries in Asia, Latin America and Eastern Europe. The profitable growth of our business in emerging markets is a significant focus of our long-term growth strategy and our regional results can fluctuate significantly based on economic conditions in these regions. For example, while China and other emerging markets contributed positively to our results in 2019, we believe that local economic conditions negatively impacted our results in China for the year, most notably in our IHM reportable segment with the decline in automotive production. Our business operations may be adversely affected by the current and future political environment in China, including as a result of its response to tariffs instituted by the U.S. government on goods imported from China, any trade agreements entered into between the U.S. and China, and increased tensions as a result of the two countries' relationships with Hong Kong. Our ability to operate in China or other emerging markets may be adversely affected by changes in the laws and regulations of these jurisdictions or the interpretation thereof, including those relating to taxation, import and export tariffs, raw materials, environmental regulations, land use rights, property, foreign currency conversion, the regulation of private enterprises and other matters.
In early 2020, in response to the initial outbreak of COVID-19, many of our manufacturing and other operations in China experienced limited production and/or closure; as the outbreak spread beyond this region, our facilities in other countries were similarly impacted, most significantly in South Asia. Substantially all of our manufacturing and other facilities are currently open, but, many of our employees are still unable to travel within and outside their countries. The pandemic and any other adverse development in emerging markets could have a material adverse effect on our business.
There could be further restrictions on our ability to travel or disruptions in our supply chain or ability to manufacture our products, as well as temporary closures of our facilities or those of our suppliers or customers, any of which could impact our sales and operating results. Although the outbreak is believed to have originated in China, substantially more cases have been confirmed in most other countries. The extent to which the pandemic will impact our financial results is dependent on future developments, which are uncertain and unpredictable. This widespread health crisis has adversely affected the economies and financial markets in impacted countries, and further escalation of the current health crisis could potentially lead to a more significant economic downturn that could adversely affect demand for our products and negatively impact our business. We expect that COVID-19 will adversely impact results for our fourth quarter and full year 2020; while we will take measures to try to mitigate this impact, there can be no assurance that these actions will be able to partially or fully offset the impact.
If we are unable to successfully expand our business in emerging markets or achieve the return on capital we expect as a result of our investments in these countries, our financial performance could be materially adversely affected. In addition to the risks applicable to our international operations, factors that could have a material adverse effect on our operations in these emerging markets include the lack of well-established or reliable legal systems and possible disruptions due to unstable political conditions, civil unrest or economic volatility. These factors could have a material adverse effect on our business by decreasing consumer purchasing power, reducing demand for our products or increasing our costs.
38
We have recently acquired companies and are likely to acquire other companies. Acquisitions come with significant risks and uncertainties, including those related to integration, technology and employees.
To grow existing businesses and expand into new areas, we have made acquisitions and are likely to continue doing so. In recent years, we completed the acquisition of the European business of Mactac, a leading manufacturer of high-quality pressure-sensitive materials serving several graphics, specialty labels and industrial tapes segments, for $220 million. We also completed the following acquisitions for an aggregate of approximately $340 million: Yongle Tape Ltd., a China-based manufacturer of specialty tapes and related products used in a variety of industrial markets; Finesse Medical Ltd., an Ireland-based manufacturer of healthcare products used in the management of wound care and skin conditions; and the net assets of Hanita Coatings Rural Cooperative Association Limited, an Israel-based pressure-sensitive manufacturer of specialty films and laminates, and stock of certain of its subsidiaries. In February 2020, we completed our acquisition of Smartrac’s Transponder (RFID Inlay) Division for approximately $255 million. We continue to evaluate potential acquisition targets and ensure we have a robust pipeline of opportunities.
Various risks, uncertainties, and costs are associated with acquisitions. Effective integration of systems, controls, employees, product lines, market segments, customers, suppliers, and production facilities and cost savings can be difficult to achieve and the results of integration actions are uncertain. In addition, we may not be able to retain key employees of an acquired company or successfully execute integration strategies and achieve projected performance targets for the business segment into which an acquired company is integrated. Both before and after the closing of an acquisition, our business and that of the acquired company may suffer due to uncertainty or diversion of management attention. Future acquisitions could result in debt, dilution, liabilities, increased interest expense, restructuring charges and amortization expenses related to intangible assets. There can be no assurance that acquisitions will be successful and contribute to our profitability. Further, we may not be able to identify value-accretive acquisition targets that support our strategy of increasing our exposure to high value product categories or execute additional acquisitions in the future.
As a manufacturer, our sales and profitability are dependent upon the cost and availability of raw materials and energy, which are subject to price fluctuations, and our ability to control or offset increases in raw material and labor costs. Raw material cost increases could materially adversely affect our business.
The environment for raw materials used in our businesses could become challenging and volatile, impacting availability and pricing. Additionally, energy costs can be volatile and unpredictable. Shortages and inflationary or other increases in the costs of raw materials, labor and energy have occurred in the past, and could recur. In 2018, we implemented targeted price increases in our LGM reportable segment in all regions to address raw material inflation that moderated in 2019. Our performance depends in part on our ability to offset cost increases for raw materials by raising our selling prices or re-engineering our products.
Also, it is important for us to obtain timely delivery of materials, equipment, and other resources from suppliers, and to make timely delivery to customers. We may experience supply chain interruptions due to natural and other disasters or other events, like COVID-19, or our existing relationships with suppliers could be terminated in the future. Any such disruption to our supply chain could have a material adverse effect on our sales and profitability, and any sustained interruption in our receipt of adequate supplies could have a material adverse effect on our business.
Changes in our business strategies may increase our costs and could affect the profitability of our businesses.
As our business environment changes, including as a result of COVID-19, we have adjusted and may need to further adjust our business strategies or restructure our operations or particular businesses. We undertook a multi-year transformation of our RBIS reportable segment focused on accelerating growth through a more regionally driven business model intended to simplify our go-to-market strategy, optimize management efficiencies and consolidate our manufacturing footprint. In addition, we have initiated restructuring and investment actions across our businesses designed to increase profitability, such as the restructuring of the European footprint of our LGM reportable segment, which began in 2018 and continued in 2019, and actions taken in our IHM reportable segment in 2019 to improve speed, reduce complexity and lower costs. We have also reduced costs across our company in response to COVID-19. As we continue to develop and adjust our growth strategies, we may invest in new businesses that have short-term returns that are negative or low and whose ultimate business prospects are uncertain or could prove unprofitable. We cannot provide assurance that we will achieve the intended results of any of our business strategies, which involve operational complexities, consume management attention and require substantial resources and effort. If we fail to achieve the intended results of such actions, our costs could increase, our assets could be impaired, and our returns on investments could be lower.
39
Our profitability may be materially adversely affected if we generate less productivity improvement than projected.
We engage in restructuring actions, including as a result of COVID-19, intended to reduce our costs and increase efficiencies across our business segments. For example, we undertook a multi-year transformation of our RBIS reportable segment focused on accelerating growth through a more regionally driven business model intended to simplify our go-to-market strategy, optimize management efficiencies and consolidate our manufacturing footprint. We intend to continue efforts to reduce costs in all our businesses, which have in the past included, and may continue to include, facility closures and square footage reductions, headcount reductions, organizational restructuring, process standardization, and manufacturing relocation. The restructuring of the European footprint of our LGM reportable segment business, which began in 2018 and continued in 2019, and actions taken in our IHM reportable segment to improve speed, reduce complexity and lower costs are examples of these activities. We estimate incremental savings from restructuring actions, net of transition costs, of $60 million to $70 million in fiscal year 2020. The success of these efforts is not assured and targeted savings may not be realized. In addition, cost reduction actions could expose us to production risk, loss of sales and employee turnover.
In addition, we expect net temporary cost savings of approximately $150 million to partially offset the negative impact of COVID-19 on volume. Cost saving actions have included deferrals of planned compensation increases, hiring freezes, overtime and temporary labor reductions, shift reductions and furloughs, temporary production shutdowns, and travel and other discretionary spending reductions. In addition, we have benefitted from lower incentive compensation costs for 2020 as a result of the impact of COVID-19 on our business. We anticipate that these actions will partially offset the negative impact on our business resulting from COVID-19, but cannot assure you that they will be sufficient.
Difficulty in the collection of receivables as a result of economic conditions or other market factors could have a material adverse effect on our business.
Although we have processes to administer credit granted to customers and believe our allowance for credit losses is adequate, we have experienced – including an approximately 70% increase in our allowance for credit losses from $27.1 million to $45.8 million in the first nine months of 2020 as a result of COVID-19 – and in the future may experience losses as a result of our inability to collect some of our accounts receivable. The financial difficulties of a customer could result in reduced business with that customer. We may also assume higher credit risk relating to receivables of a customer experiencing financial difficulty. If these developments were to occur, our inability to collect on our accounts receivable from major customers could substantially reduce our cash flows and income and have a material adverse effect on our business.
Our stock price may be volatile, which, among other things, could cause our tax rate to vary significantly.
Changes in our stock price may affect our access to, or cost of financing from, capital markets and may affect our stock-based compensation arrangements, among other things. Our stock price, which increased significantly in 2019 after having experienced a decline in 2018, and may experience substantial volatility, is influenced by changes in the overall stock market and demand for equity securities in general, as seen in our first fiscal quarter 2020 (with a stock price low of $76.96 and high of $141.09); second fiscal quarter 2020 (with a stock price low of $93.29 and high of $125.67); and third fiscal quarter (with a stock price low of $109.99 and high of $129.74) due in part to the impact of COVID-19. Other factors, including our financial performance on an absolute basis and relative to our peers and competitors, as well as market expectations of our performance, the level of perceived growth of our industries, and other company-specific factors, can also materially adversely affect our stock price. There can be no assurance that our stock price will not be volatile in the future.
In any period in which our stock price is higher than the grant price of the stock-based compensation vesting or being exercised in that period, we are required to recognize excess tax benefits that would decrease our effective tax rate. Conversely, if our stock price is lower than the grant price of the stock-based compensation vesting or being exercised in that period, we are required to recognize tax charges that would increase our effective tax rate. This tax effect is dependent on our stock price and there can be no assurance that we will recognize similar levels of excess tax benefits in future years.
40
We cannot guarantee that we will continue to repurchase shares of our common stock or pay dividends on our common stock or that repurchases will enhance long-term stockholder value. Changes in our levels of stock repurchases or dividends could affect our stock price and increase its volatility.
In April 2019, our Board authorized the repurchase of shares of our common stock with a fair market value of up to $650 million, in addition to the amount of shares that were available for repurchase under a previous authorization. As of December 28, 2019, shares of our common stock in the aggregate amount of $644.7 million remained authorized for repurchase under that Board authorization. Beginning in the first quarter of 2020, we temporarily paused our share repurchase activity in response to COVID-19 after buying approximately $45 million of our stock in the quarter. We resumed repurchases late in the third quarter of 2020. Share repurchases under our repurchase program may be made through a variety of methods, which may include open market purchases, privately negotiated transactions, block trades or accelerated share repurchase transactions. Our share repurchase authorizations do not obligate us to acquire any specific number of shares or to repurchase any specific number of shares for any fixed period. The timing and amount of repurchases, if any, are subject to market and economic conditions, applicable legal requirements and other relevant factors. Our repurchase of common stock may be limited, suspended or discontinued at any time at our discretion and without prior notice.
Although we increased our quarterly dividend rate by approximately 7% in October 2020, having earlier this year maintained it due to the impact of COVID-19, there can be no assurance that we will maintain this increased rate, particularly if the situation deteriorates. Additionally, any future dividends that may be declared and paid from time to time are subject to market and economic conditions, applicable legal requirements and other relevant factors. We are not obligated to continue a dividend for any fixed period, and the payment of dividends could be suspended or discontinued at any time at our discretion and without prior notice. We will continue to retain future earnings to develop our business, as opportunities arise, and evaluate on a quarterly basis the amount and timing of future dividends based on our operating results, financial condition, capital requirements and general business conditions. The amount and timing of any future dividends may vary, and the payment of any dividend does not assure that we will pay dividends in the future.
In addition, any future repurchases of our common stock or payment of dividends, or any determination to cease repurchasing stock or paying dividends, could affect our stock price and increase its volatility. The existence of a share repurchase program and any future dividends could cause our stock price to be higher than it would otherwise be and could potentially reduce the market liquidity for our stock. Additionally, any future repurchases of our common stock or payment of dividends could impact our ability to finance future growth and to pursue possible future strategic opportunities and acquisitions. Although our share repurchase program is intended to enhance long-term stockholder value, there is no assurance that it will do so because the market price of our common stock may decline below the levels at which we repurchased shares of stock and short-term stock price fluctuations could reduce our program’s effectiveness.
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
(a) | Not Applicable |
(b) | Not Applicable |
(c) | Repurchases of Equity Securities by Issuer |
Repurchases by us or our “affiliated purchasers” (as defined in Rule 10b-18(a)(3) of the Exchange Act) of registered equity securities in the three fiscal months of the third quarter of 2020 are shown in the table below. Repurchased shares may be reissued under our long-term incentive plan or used for other corporate purposes.
|
|
| Total number of shares |
| Approximate dollar | |||||
Total number | Average | purchased as part of | value of shares that may | |||||||
of shares | price paid | publicly announced | yet be purchased under | |||||||
Period(1) | purchased(2) | per share | plans(2)(3) | the plans(4) | ||||||
June 28, 2020 – July 25, 2020 |
| — | $ | — |
| — | $ | 599.5 | ||
July 26, 2020 – August 22, 2020 |
| — |
| — |
| — |
| 599.5 | ||
August 23, 2020 – September 26, 2020 |
| 58.0 |
| 120.28 |
| 58.0 |
| 592.5 | ||
Total |
| 58.0 | $ | 120.28 |
| 58.0 | $ | 592.5 |
(1)The periods shown are our fiscal periods during the thirteen-week quarter ended September 26, 2020.
(2)Shares in thousands.
(3)In April 2019, our Board authorized the repurchase of shares of our common stock with a fair market value of up to $650 million, exclusive of any fees, commissions or other expenses related to such purchases. This Board authorization will remain in effect until shares in the amount authorized thereunder have been repurchased.
(4)Dollars in millions.
41
ITEM 3. DEFAULTS UPON SENIOR SECURITIES
Not Applicable
ITEM 4. MINE SAFETY DISCLOSURES
Not Applicable
ITEM 5. OTHER INFORMATION
Not Applicable
ITEM 6. EXHIBITS
Exhibit 3.1(i) | |
Exhibit 3.1(ii) | |
Exhibit 31.1* | Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 |
Exhibit 31.2* | Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 |
Exhibit 32.1** | Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 |
Exhibit 32.2** | Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 |
Exhibit 101.INS*** | Inline XBRL Instance Document ‒ the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. |
Exhibit 101.SCH*** | Inline XBRL Extension Schema Document |
Exhibit 101.CAL*** | Inline XBRL Extension Calculation Linkbase Document |
Exhibit 101.LAB*** | Inline XBRL Extension Label Linkbase Document |
Exhibit 101.PRE*** | Inline XBRL Extension Presentation Linkbase Document |
Exhibit 101.DEF*** | Inline XBRL Extension Definition Linkbase Document |
Exhibit 104*** | Inline XBRL for the cover page of this Quarterly Report on Form 10-Q, included as part of this Exhibit 101 inline XBRL document set |
* | Filed herewith. |
** | Furnished herewith. |
*** | Furnished herewith. Pursuant to Rule 406T of Regulation S-T, the Interactive Data Files on Exhibit 101 hereto are deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act, are deemed not filed for purposes of Section 18 of the Exchange Act and otherwise are not subject to liability under those sections. |
42
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
AVERY DENNISON CORPORATION | |
(Registrant) | |
/s/ Gregory S. Lovins | |
Gregory S. Lovins | |
Senior Vice President and Chief Financial Officer | |
(Principal Financial Officer) | |
/s/ Lori J. Bondar | |
Lori J. Bondar | |
Vice President, Controller, Treasurer, and Chief Accounting Officer | |
(Principal Accounting Officer) | |
October 27, 2020 |
43
Exhibit 31.1
CERTIFICATION OF CHIEF EXECUTIVE OFFICER
PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
CERTIFICATION
I, Mitchell R. Butier, certify that:
1. | I have reviewed this Quarterly Report on Form 10-Q of Avery Dennison Corporation; |
2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
4. | The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
a) | designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
b) | designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
c) | evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
d) | disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and |
5. | The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): |
a) | all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and |
b) | any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. |
| /s/ Mitchell R. Butier |
| Mitchell R. Butier |
October 27, 2020 | Chairman, President and Chief Executive Officer |
Exhibit 31.2
CERTIFICATION OF CHIEF FINANCIAL OFFICER
PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
CERTIFICATION
I, Gregory S. Lovins, certify that:
1. I have reviewed this Quarterly Report on Form 10-Q of Avery Dennison Corporation;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
| /s/ Gregory S. Lovins |
| Gregory S. Lovins |
| Senior Vice President and Chief Financial Officer |
October 27, 2020 | |
Exhibit 32.1
CERTIFICATION OF CHIEF EXECUTIVE OFFICER*
PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
Pursuant to 18 U.S.C. Section 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of Avery Dennison Corporation (the “Company”) hereby certifies, to the best of his knowledge, that:
(i) | the Quarterly Report on Form 10-Q of the Company for the fiscal quarter ended September 26, 2020 (the “Report”) fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and |
(ii) | the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Dated: October 27, 2020 | |
| /s/ Mitchell R. Butier |
| Mitchell R. Butier |
| Chairman, President and Chief Executive Officer |
* | The above certification accompanies the Company’s Quarterly Report on Form 10-Q and is furnished, not filed, as provided in SEC Release 33-8238, dated June 5, 2003. |
Exhibit 32.2
CERTIFICATION OF CHIEF FINANCIAL OFFICER*
PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
Pursuant to 18 U.S.C. Section 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of Avery Dennison Corporation (the “Company”) hereby certifies, to the best of his knowledge, that:
(i) | the Quarterly Report on Form 10-Q of the Company for the fiscal quarter ended September 26, 2020 (the “Report”) fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and |
(ii) | the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Dated: October 27, 2020 | |
| /s/ Gregory S. Lovins |
| Gregory S. Lovins |
| Senior Vice President and Chief Financial Officer |
* | The above certification accompanies the Company’s Quarterly Report on Form 10-Q and is furnished, not filed, as provided in SEC Release 33-8238, dated June 5, 2003. |